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Abstract 
 
(A) Most azobenzene-based photoswitches require UV light for photoisomerization, which limit 
their applications in biological systems due to possible photodamage. Cyclic azobenzene 
derivatives, on the other hand, can undergo cis-trans isomerization when exposed to visible light. 
A shortened synthetic scheme was developed for the preparation of a building block containing 
cyclic azobenzene and D-threoninol (cAB-Thr). trans-Cyclic azobenzene was found to thermally 
isomerize back to the cis-form in a temperature-dependent manner. cAB-Thr was transformed into 
the corresponding phosphoramidite and subsequently incorporated into oligonucleotides by solid 
phase synthesis. Melting temperature measurement suggested that incorporation of cis-cAB into 
oligonucleotides destabilizes DNA duplexes, these findings corroborate with circular dichroism 
measurement. Finally, Fluorescent Energy Resonance Transfer experiments indicated that trans-
cAB can be accommodated in DNA duplexes.  
 (B) Inverse Electron Demand Diels-Alder reactions (IEDDA) between trans-olefins and tetrazines 
provide a powerful alternative to existing ligation chemistries due to its fast reaction rate, 
bioorthogonality and mutual orthogonality with other click reactions. In this project, an attempt 
was pursued to synthesize trans-cyclooctene building blocks for oligonucleotide labeling by 
reacting with BODIPY-tetrazine. Rel-(1R-4E-pR)-cyclooct-4-enol and rel-(1R,8S,9S,4E)-
Bicyclo[6.1.0]non-4-ene-9-ylmethanol were synthesized and then transformed into the 
corresponding propargyl ether. Subsequent Sonogashira reactions between these propargylated 
compounds with DMT-protected 5-iododeoxyuridine failed to give the desired products. Finally a 
methodology was pursued for the synthesis of BODIPY-tetrazine conjugates that will be used in 
future IEDDA reactions with trans-cyclooctene modified oligonucleotides.  
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CHAPTER 1: Regulation of nucleic acids functions by photoresponsive 
molecules 
 
1.1 Introduction to nucleic acids  
Nucleic acids are macromolecules made up of a linear array of monomers called nucleotides, 
each composed of a pentose sugar, a nucleobase (purine and pyrimidine) and a phosphate diester 
group. The purine bases, adenine (Ade) and guanine (Gua) as well as the pyrimidine bases, 
cytosine (Cyt) and thymine (Thy) can exist in different chemical isomeric forms (tautomers); 
however, the equilibrium favors the keto and amino forms (Figure 1-1) by a ratio of about 104 to 
1. Two types of nucleic acids exist in nature, deoxyribonucleic acid (DNA) and ribonucleic acid 
(RNA).  
        
Figure 1-1. Structures of the favored tautomers of purine and pyrimidine bases, sugar units and phosphate 
groups in nucleic acids.  
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The sugar units in DNA are D-2-deoxyriboses, and they are linked to one another by the 
phosphodiester bridges. Specifically, the 3’-hydroxyl group of the sugar moiety of one nucleotide 
is esterified to a phosphate group, which in turn is joined to the 5’-hydroxyl group of the adjacent 
nucleoside, essentially forming the backbone of the nucleic acids. The nucleobases are joined from 
a ring nitrogen to C-1’ of the pentose sugar.1  
The covalent structure of RNA differs from that of DNA in two respects. First, the sugar units 
are D-riboses which have extra hydroxyl group at 2’ position as compared with D-2-deoxyribose 
found in DNA. Second, thymidine (Thy) is replaced with uracil (Ura) (Figure 1-2).2  
 
Figure 1-2. Backbones of DNA and RNA.2 
In living organisms, most RNAs are single-stranded while most DNA molecules are double 
stranded. The two strands of DNA are antiparallel to each other; one strand runs in a 5’-3’ direction 
whereas the other runs in a 3’-5’ direction. Each strand serves as a template in DNA replication .1 
The nucleobases in the two separate anti-parallel DNA strands form specific hydrogen bonds in 
such a way that a helical structure is formed. In the model of DNA double helix first  described by 
Watson and Crick in 1953, guanine forms three sets of hydrogen bonds with cytosine and adenine 
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forms two sets of hydrogen bonds with thymine.3 The stacking of base pairs contributes to the 
stability of DNA helix by the hydrophobic effect and dipole interactions (Figure 1-3).4, 5 
 
Figure 1-3. Watson-Crick base pairs found in the usual double stranded DNA.4 
Because the glycosidic bonds of a base pair are not diametrically opposite to each other, two 
grooves arise, major and minor grooves. In B-DNA, the major groove is wider (12 versus 6 Å) and 
deeper (8.5 versus 7.5 Å) than the minor groove (Figure 1-3).4, 5 
X-Ray diffraction analyses of single crystals of DNA revealed that DNA exhibits three 
different conformations A- , B- and Z-forms, of which B-DNA is the most common. In this form, 
the double helix is right-handed with a mean twist angle of 36°, giving 10 nucleotides per helical 
turn. The stacked base pairs form a central core surrounded by the phosphate backbone.1The center 
of the helix is a relatively chemically inert space for  storing the genetic information.3 
DNA and RNA are responsible for the storage and flow of genetic information in biological 
systems.6 DNA sequence information is converted to RNA in a process called transcription. Then 
the sequence encoded in the RNA molecule is decoded and converted to an amino acid sequence 
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in a process called translation (Figure 1-4). In addition, nucleic acids have been found to possess 
various functions and applications, such as RNA interference (RNAi) and antisense 
oligonucleotides, riboswitches, DNAzymes, aptamers, molecular diagnostics such as nucleic acid 
microarrays, and as building blocks for nanoscale material. Therefore, study of these biological 
processes, will provide insight into biochemical functions of nucleic acids. Moreover, identifying 
and examining the nature of DNA-protein interactions is a crucial prerequisite to understand the 
molecular basis of fundamental processes such as DNA replication, packaging, and DNA damage 
and repair.7 
 
Figure 1-4. A diagram of the central dogma showing the information flow from DNA to RNA to proteins. 
1.2 Functional regulation of biomolecules 
Recently, much attention has been focused on the artificial control of gene expression to study 
cellular processes as an important tool to investigate the details of cellular signaling and 
differentiation as well as  disease progression.8 
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Regulation of nucleic acid information flows has been achieved by different techniques such 
as small molecules, antigene and antisense oligonucleotides, and RNA interference (RNAi). 
Despite their efficiency, these techniques do not provide precise control of dosages and sites of 
action.9 
One strategy to achieve spatiotemporal control or to enhance the selectivity in regulating a 
particular cellular function is to subject the system to the control of either internal or external 
stimuli. 10 In this respect, spatial and temporal control of cellular processes using light could 
provide unparalleled opportunities to study biological processes such as organism development 
and disease progression.11 
Light provides excellent potential as external trigger signal as: i) it is generally noninvasive at 
a range of wavelengths, ii) it  is orthogonal toward most elements of living systems,12 iii) it is easy 
to control irradiation time and local excitation without the need for direct contact to the material, 
and iv) controlling of excitation wavelength can be accomplished through the design of photo-
responsive molecules.10, 13  
One example of naturally occurring light-dependent processes occurs in the plant, where light 
influences plant development at various levels of gene expression. In the nuclear-cytosolic 
compartment this regulation takes place primarily at the transcriptional level. However, the photo-
regulation of chloroplast genes has been observed mainly at the level of translation.14 Another 
example of light-dependent processes involves phototropins, a class of light-activated kinases. In 
this cascade, light initiates signaling in these proteins by generating a covalent protein–flavin 
mononucleotide (FMN) adduct within sensory Per-ARNT-Sim (PAS) domains.15 
Two strategies for the introduction of light-sensitivity into biomolecules have been 
investigated. The first one is usually referred to as “caging” and involves the modification of a 
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biologically active substance with a photolabile “protecting” group to make it temporarily inactive. 
The second strategy involves functionalization with bistable molecular photoswitches, so that 
these molecules can be reversibly switched between an active and an inactive state.9, 12 
1.3   Irreversible photoregulation of nucleic acid properties by caged molecules 
Photolabile caged compounds are biologically inert precursors of active molecules, which 
upon exposure to light release the active species at its site of action.16 Photolysis of caged 
molecules represents a convenient approach to achieve spatiotemporal control of biomolecules 
with light as an external trigger. The concept behind the caging technique is that the biomolecule 
of interest can be made biologically inert (or caged) by chemically modifying its structure with a 
photoremovable protecting group (PPG). Illumination gives rise to active species, allowing 
spatiotemporal control of the targeted process.17 
The criteria for the design of a good PPG depend on the application. Ideally, caged compounds 
should be soluble and stable in the targeted media, and they must be biologically inert before 
photolysis. The uncaging, or photodeprotection, step should occur with high quantum yield and at 
wavelengths well above 300 nm to avoid damaging the biological entity. It is also important that 
the rate of photodeprotection is faster than the process being studied, and the by-products 
accompanying the released bioactive reagent should be nontoxic and biocompatible.9, 18 
Before the term “caging” was coined, Martinek and coworkers performed a series of studies 
in 1971 on peptidase α-chymotrypsin (CT).19 The reaction between CT 1 and cis-cinnamoyl 
imidazole 2 resulted in the formation of cis-acylated product 3 (Scheme 1-1). As a result, α-
chymotrypsin was temporarily deactivated. Only upon isomerization to the trans-adduct 5 was the 
cinnamoyl group cleaved, regenerating the active CT enzyme 1 which can then cleave the substrate 
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tyrosine ester to tyrosine to be converted by tyrosinase into the pigment melanine. As such, cis-
cinnamoylated CT could be called “caged”.19 
 
Scheme 1-1. Photoregulation of peptidase α-chymotrypsin.9 
In 1978 Koplan et al. synthesized a photolabile precursor of adenosine triphosphate ATP 7 
(Scheme 1-2), and introduced the term “caged” for the first time to describe these compounds.  
The γ-phosphate of ATP was masked with a photoremovable o-nitrobenzyl group. Upon irradiation 
at 350 nm, the caged ATP photolyzes to release ATP 8 and a nitrosoketone 9.20 This work paved 
the way for introducing the photorelease approach as a useful technique to study the mechanism 
of a wide range of ATP-dependent processes, including the ion-transporting ATPases, muscle 
contraction and time-resolved structural studies of the sarcoplasmic reticulum Ca2+ pump.21  
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Scheme 1-2. Overall photolysis reaction of caged ATP 7.9 
Figure 1-5 shows the most commonly used caging groups for the photoregulation of nucleic 
acids  and gene expression such as o-nitrobenzyl (ONB) and its derivative  nitrophenylethyl (R = 
Me, NPE) 10,22 2-(2-nitrophenyl) propyl (NPP) 11,23 nitrodibenzofurane chromophore 12,24 
coumarin based group  [7-(dimethylamino) coumarin-4-yl] methyl (DMACM) 13,25 8-bromo-7-
hydroxyquinoline (BHQ) 14,26 and ketoprofen derivative 15.27 
 
Figure 1-5. The most commonly used caging groups.9 
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1.4 Photoregulation of DNA hybridization using caged molecules 
DNA hybridization is a process where two complementary strands join together to form 
duplex DNA. Nucleic acid hybridization is responsible for the fundamental roles that these 
important molecules play in the biological system. It is also fundamental in many molecular 
biology techniques such as polymerase chain reaction (PCR) and detection of specific DNA 
sequences via hybridization. As such, regulation of nucleic acid hybridization using external light 
stimuli provides spatiotemporal control of processes where nucleic acid hybridization is critical. 
In 2003, Saito et al. demonstrates a light-based technique using a photocleavable cage 
compound to transiently block DNA hybridization.28 They developed caged molecular beacons, 
which are oligonucleotide hybridization probes, to regulate the hybridization of single-stranded 
DNA with its complementary sequence. In this study, molecular beacon is modified with a 
naphthalene quencher at the 5ʹ-end and a photolabile pHP (4-hydroxyphenacyl ester) group to 
which biotin is linked at the 3ʹ-end. In the absence of complementary DNA sequence, the 
photoreaction was inefficient because the molecular beacon containing the photoactive group was 
in the closed form 16, i.e. a stem and loop structure, whereas irradiation of the open form 17 led 
to hybridization with the complementary strand, effectively moving the naphthalene quencher 
away to allow the cleavage of photolabile group releasing the biotin residue 18 (Scheme 1-3).28 
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Scheme 1-3. Photoregulation of molecular beacon hybridization using pHP photolabile group.28 
In 2005 Bilal Ghosn et al. explored the use of 1-(4,5-dimethoxy-2-nitropheny1)ethyl ester 
(DMNPE) of the phosphate backbone to regulate DNA hybridization.29 In this experiment, the 
photolabile (DMNPE) group was attached to the DNA phosphate backbone as shown in 19 
(Scheme 1-4). Hybridization assay was then performed with complementary molecular beacon 20 
which does not show fluorescence until hybridized to a complementary DNA. It was found that 
DMNPE-caged DNA does not hybridize with the molecular beacon until it is photoactivated with 
365 nm light to cleave the DMNPE group. Fluorescent experiment results and gel shift assays 
confirmed that up to 80% the hybridization of modified DNA was achieved after irradiation with 
light when an average of 14–16 DMNPE groups were incorporated in the DNA 19.29  
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Scheme 1-4. Hybridization assay of caged DNA and complementary molecular beacon.29 
1.5 Photoregulation of DNA transcription and gene expression using caged molecules 
Haselton and co-workers were the first to study the possibility of light activated transcription 
with modified nucleic acids.30 They developed caged plasmid DNAs which encode for luciferase 
or GFP expression. The DMNPE-caging groups were introduced to the phosphate backbone in an 
unselective manner using 1-(4,5-dimethoxy-2-nitrophenyl)ethyl ester as a reagent (as in 21, Figure 
1-6). The purified photocaged plasmids were then introduced to rat skin cells or HeLa cells. The 
GFP expression in both cells was temporarily blocked until exposed to 355 nm light which induces 
the GFP expression in a dose-dependent manner.30  
 
Figure 1-6. DMNPE caging group on the phosphate backbone of DNA.30 
A similar approach was employed by Okamoto et al. to design caged GFP-mRNA.31Thus, the 
mRNA was caged with a coumarin-derivative group Bhc (6-bromo-7-hydroxycoumarin-4-
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ylmethyl) using 22 as reagent (Figure 1-7),32 similar to the previous study. The caged mRNA was 
then introduced to zebrafish embryos through injection at the one-cell stage. While only 4% GFP 
expression was seen with the caged mRNA, indicating very efficient blocking, up to 18% (4.5-
fold enhancement) and 23% (6-fold enhancement) GFP expression were seen after 10 s and 20 s 
irradiation with 350-365 nm light, respectively.31  
 
Figure 1-7. A structure of Bhc caging group precurser and its applications for caging RNA.32 
Light regulation can also be accomplished by installation of a caging group on a nucleoside 
phosphoramidite followed by introduction of “caged” nucleosides into nucleic acid sequences by 
solid phase synthesis.32 The caging group can effectively block the interaction or basepairing 
properties with its complementary sequence.33 In this regard, Heckel and co-workers reported the 
synthesis of caged thymidine phosphoramidites and their usage for controlling DNA transcription 
by light.6 In this work, thymidine was modified at the O4-position with a photolabile o-
nitrophenyl-isopropyl (NPP) group (as in 23 in Figure 1-8).34 The chemical modification 
introduced on thymidine was recognised as a mismatch by the T7 RNA polymerase, preventing 
the transcription of the duplex DNA. After irradiation, the same amount of transcription product 
was formed as in the control reaction with the uncaged sequence 6 (Figure 1-8).  
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Figure 1-8. Strategy of controlling RNA transcription with a sense oligodeoxynucleotide (sODN) primer 
that contains one or more caged thymidine nucleobases; where asODN is antisense oligodeoxynucleotide.34 
Thermal denaturation experiments were performed in order to investigate the effect of NPP 
caged thymidine on the duplex stability. It was found that introduction of just one caged nucleotide 
leads to a significant reduction (by up to 5°C) in the melting temperature (Tm). While with three 
caged nucleotides the Tm decreased by 21.5°C. After irradiation with 366 nm for 30 min, the Tm of 
caged DNA was restored to the same as the unmodified oligomer (Table 1-1).6  
Table 1-1. Tm before and after (in parenthesis) irradiation of caged NPP-T25 (error ca. 0.7°C). Tm of 
unmodified T25 is 53.8 (54.0)°C.6 X = NPP-dT. 
Sequence 5’-T8TTTTXTTTTT8–3’ 5’-T8TTTXXXTTTT8-3’ 5’-T8XTTTXTTTXT8-3’ 
Tm (°C) 48.5 (54.0) 44.5 (52.7) 32.3 (53.2) 
 
Figure 1-9 shows examples of caged nucleosides with different caging groups used for light 
responsive regulation of DNA and RNA, which include: NPOM-dT 24, NPP-dC 25, NPE-dA 26,33 
NPE-G 27, NPE-U 2835 and NPE-A 29.35, 36  
Morpholino oligonucleotides (MOs) are synthetic DNA analogues in which the sugar 
phosphate backbone is replaced with morpholino moieties. Caged MOs have been found useful 
for the regulation of gene function in both cell culture and living embryos. Dieters et al.38 reported 
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the synthesis of morpholino oligomers caged with a photolabile 6-nitropiperonyloxymethyl 
(NPOM) caging group 30 (Figure 1-10). In this study, the authors demonstrated that a caged MO 
that targets enhanced green fluorescent protein (EGFP) inhibits EGFP expression only after 
exposure to UV light of 365 nm in both transfected cells and living zebrafish and xenopus frog 
embryos.38   
 
Figure 1-9. Examples of caged nucleosides with different caging groups for the nucleobases.33, 35, 36 
 
 
 
 
Morpholino Sequence 
EGFP-MO0 ACAGCTCCTCGCCCTTGCTCACCAT 
EGFP-MO4 ACAGCT*CCT*CGCCCT*TGCT*CACCAT 
       T* denotes caged monomer, Trt is triphenylmethyl 
Figure 1-10. Caged morpholino monomer 30, and morpholino oligomers containing the caged monomer.37 
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Caging groups are synthetically malleable and accessible, offering a wide range of structures 
for designed applications. As a result they offer excellent spatial and temporal control for the 
substrate release. However, photolysis of these compounds forms potentially toxic by-products 
such as o-nitrosobenzaldehyde, limiting their applications in the photoregulation of biological 
systems.12 Further, bidirectional regulation is not possible with the caging approach. 
1.6 Reversible photoregulation of nucleic acids by photoswithches 
Photoswitches are a class of compounds that undergo reversible photochemistry in that they 
can be shifted between at least two different states or forms.13, 38, 39 These two forms differ in their 
absorption spectra and other physical properties, such as their redox potential, fluorescent 
intensity, acid/base strength, dielectric constant, dipolar moment, and molecular shape.13 
A variety of synthetic organic molecules have been investigated for reversible photocontrol 
of biomolecules (Table 1-2). These molecules either switch upon irradiation between the cis and 
trans isomers, such as azobenzenes, stilbenes, and hemithioindigos, or interconvert between closed 
and open forms, such as spiropyrans, diarylethenes, and fulgides.12 
In terms of thermal stability of the photogenerated isomer, photoswitches can be classified in 
two categories: P-type (photochemically reversible type), which do not isomerize back to the initial 
isomer even at elevated temperatures, e.g. fulgides and diarylethenes, and T-type (thermally 
reversible type), where the photogenerated isomer can reverse back to original state by either 
heating or irradiation with light, e.g. azobenzenes, stilbenes and spiropyranes.13 
Table 1-2. Selected molecular structures of photoswitches introduced into biomolecules.12 
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Photoswitches Isomerization λ1/λ2 
Stilbenes 
 
UV/vis 
Hemithioindigos 
 
UV/vis  
(∆T) 
Spiropyrans 
 
UV/vis  
(∆T) or 
vis/UV 
Diarylethenes 
 
UV/vis 
Thiophenefulgides 
 
UV/vis 
Azobenzenes 
 
UV/vis 
(∆T) 
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1.6.1 Stilbenes 
The stilbenes system 31, 32 (Table 1-2) which is an example of the general class of 
diarylethene chromophore, undergoes an analogous trans-cis isomerization.40 Thermal 
isomerization is negligible at room temperature because the barrier of the thermal cis-trans 
reisomerization is 41−46 kcal/mol. Letsinger and Wu were the first to incorporate a 
photoswitchable unit into nucleic acid structure in the form of stilbene as a backbone linker of two 
DNA oligonucleotides.12 In this study, stilbene dicarboxamide bridge was used to introduce 
photoreversibility to the hairpin structure 43 (Figure 1-11). The cis form of the stilbene unit was 
found to destabilize hairpin structure, because its geometry is too short a linker to properly stack 
with the underlying helix. For instance, in the strand T6-[ST]-A6, a shift of 10°C in Tm was 
observed for the trans (59°C) and cis (49°C) isomers in the presence of 100 mM NaCl.41   
 
Figure 1-11. Stilbene derivatives for photoreversible regulation of hairpin structure. 12 
A major drawback of stilbenes is their tendency to undergo irreversible cyclization and 
oxidation in the cis form.42 
1.6.2  Spiropyrans 
In these photochromic compounds 35, the Cspiro−O bond undergoes heterolytic cleavage upon 
exposure to UV light (360−370 nm),43 resulting in the formation of a zwitterionic conjugated 
system, known as the merocyanine form, or the open-form 36 (Table 1-2).12, 44 The isomerization 
process is accompanied by a very large change in polarity which is reflected by changes in 
hydrophilicity/hydrophobicity. The back isomerization can be achieved both thermally and 
photochemically with visible (>460 nm) light.12 
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The importance of these molecules for the photoregulation of nucleic acids can be attributed 
to the assumption that the ring-closed non-planar spiropyran form 35 is unable to insert into the 
base stack whereas the open and planar merocyanine form could potentially intercalate. This 
assumption was supported experimentally by Wagenknecht and Beyer’s study.45 In this study, the 
spirobenzopyran was incorporated as an internal modification into DNA sequences by two 
different synthetic strategies: incorporation of spiropyran phosphoramidite to DNA by solid phase 
synthesis and post-synthetic ‘click’-type ligation which gives products such as 44 (Figure 1-12).45  
Figure 1-12. Spiropyran-modified DNA duplexes.45  
The Tms of those spiropyran-modified duplexes were measured (Table 1-3). The duplexes showed 
a significant destabilization compared with the Tms of their corresponding unmodified duplexes, 
i.e. X = T in Figure 1-12.   
Table 1-3. Tms of spiropyran-modified DNA duplexes in comparison to the corresponding unmodified 
duplexes.45 
Duplex Tm (°C) Tm’ (°C) ∆Tm 
DNA1 47.9 66.0 –18.1 
DNA2 50.0 62.5 –12.5 
DNA3 48.0 61.0 –13.0 
DNA4 47.8 68.0 –20.2 
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Surprisingly, ring opening of the spiropyran-modified DNA duplexes with UV light could not 
be achieved although the same irradiation conditions have been used for switching spiropyran 
derivatives without DNA. The explanation for this observation was that the DNA nucleobases 
might quench the triplet state of the spiropyran by energy or electron transfer processes thereby 
inhibiting the photoswitching process.45 
1.6.3 Diarylethene 
The first examples of these thermally irreversible molecules 37 (Table 1-2) were reported in 
the late 1960s.46 The thermal stability of diarylethene can be attributed to the low aromatic 
stabilization energies of the heterocyclic aryl groups on both sides of the alkene moiety.47 
Diarylethene photoswitches show very high fatigue resistance, as they can undergo reversible 
photoisomerization for more than 104 times.48  
Cahova and coworkers reported the synthesis of nucleoside-based diarylethene photoswitches 
in which one of the two aryl moieties of diarylethene was replaced by a nucleoside, namely 2-[2-
methyl-5-phenylthien-3-yl]cyclopent-1-ene for the photoregulation of DNA functions.49 Upon 
irradiation with light, these compounds 45 were found to undergo a highly efficient, reversible, 
rearrangement to give products such as 46 (Scheme 1-5). 
   
Scheme 1-5. New photoswitchable DNA where a pyrimidine nucleotide is part of the photoswitch.49 
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The influence of this diarylethene photoswitch on DNA transcription was investigated. 
Generally, promoters incorporating photoswitchable diarylethene gave higher amounts of product 
in their closed-ring forms than the opened-ring forms.49 
1.6.4 Azobenzenes 
Azobenzenes form one of the largest and most commonly used organic chromophores for 
optical switching applications.50 These photoswitches exist in two isomeric states, trans and cis, 
with the former being ∼10 kcal/mol more stable than the latter.51 The trans-isomer 41 (Scheme 1-
6) is virtually planar with nearly zero dipole moment; however, this polarity is considerably 
changed upon isomerization to the cis-form 42 (Scheme 1-6), which has a dipole moment of ∼3 
D.  The distance between the two carbon atoms in the 4- and 4’-positions are 9.0 and 5.5 Å for the 
trans- and cis- isomers, respectively.52 The reverse, cis to trans isomerization occurs thermally or 
can be achieved by irradiation with visible light (>460 nm).12 The photoisomerization of 
azobenzene occurs with moderate quantum yields, where ϕ Z-E = 53 % and ϕ E-Z = 24 %.53 
 
Scheme 1-6. Structural changes during the photoisomerization of azobenzene.52  
 The UV/vis spectrum of unsubstituted trans-azobenzene shows two absorption maxima. The 
trans-azobenzene isomer displays a strong absorption band at 318 nm resulting from π→π* 
transition and another weak absorption band at 432 nm indicative of the forbidden symmetry 
n→π* transition. The cis-azobenzene isomer shows a strong n→π* band at 440 nm and a weak 
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π→π* band at 260 nm. The absorption spectra of the two isomers of azobenzene are distinct but 
partially overlap, especially in the visible region.54, 55  
 
Figure 1-13. UV/Vis absorption spectra of azobenzene isomers 41 and 42 (solid line: cis-isomer; dash line: 
trans-isomer).55 (Reproduced with permission from Zimmerman, G.; L. Y.; Paik, U. J. J. Am. Chem. Soc. 
1958, 80, 3528-3531). 
The mechanism of photoisomerization of azobenzene has attracted much attention for many 
years and has given rise to controversy. For the process, two different mechanisms have been 
proposed. In the inversion mechanism, the nonbonding electron pair of each nitrogen atom may 
undergo an n→π* electronic transition with inversion at the nitrogen atom, while the rotation 
mechanism involves a simple rotation around the N=N double bond (Figure 1-14).16, 56 
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Figure 1-14. Photoisomerization pathways from trans-to cis- azobenzene and vice versa.57 
Azobenzenes are easy to synthesize in general. They possess relatively high photostationary 
states, which is defined as the equilibrium composition during irradiation, and they isomerize with 
fast photoisomerization kinetics, with low rate of photobleaching.58 Due to these features, 
azobenzenes have become the most widely used photoswitches in biological applications. 
1.6.4.1 Photoregulation of DNA functions by azobenzenes 
The incorporation of switches as nucleoside surrogates remains the gold standard in 
photoswitchable nucleic acids.56 Komiyama, Asanuma, and co-workers were the pioneers in this 
approach by using a phosphoramidite-functionalized switch as nucleoside surrogate.59 In their 
study, up to 10 azobenzene units were introduced into the DNA sequence through a D-threoninol 
linker (as shown in Figure 1-15) in order to photoregulate the formation and dissociation of DNA 
duplex. Azobenzene intercalates between the neighboring pairing bases in the trans-form which 
stabilizes the duplex formation due to its planarity. Following irradiation, the non-planar cis-form 
destabilizes the duplex, presumably due to diminished ability to intercalate (Figure 1-15).10 
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Figure 1-15. The photoregulation of DNA hybridization through incorporating azobenzene residues into 
oligonucleotides.10 
Hybridization affinity was compared by measuring the Tm of unmodified and modified DNA 
sequences.59 It was found that when azobenzenes took the trans- form, introduction of multiple 
azobenzenes did not interfere with the duplex formation compared with their unmodified 
complexes; however, the Tm uniformly decreases with the number of azobenzenes when they exist 
in the cis-form. For instance, Tm of Azo-9 which is a 20-mer with nine azobenzenes was 63.5°C 
for the trans-form, which is even higher than that of natural Azo-0 (61.5°C). In contrast, change 
of Tm by 31.5°C was observed upon trans-cis isomerization.
59  
The extent of hybridization was further investigated using a FRET (Fluorescence Resonance 
Electron Transfer) assay. Thus, fluorescein (FAM) and a fluorescent quencher (Dabsyl) were 
attached to the 5’-end of the unmodified oligomer and the 3’-end of the azobenzene-modified 
oligomers, respectively. When azobenzenes adopt the trans-form, the modified and 
complementary strands anneal, thus the fluorescence from the FAM is quenched by the Dabsyl.   
However, fluorescence is restored to varying degrees when azobenzenes exist in the cis-form 
(Figure 1-16).10 
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Figure 1-16. Oligonucleotide sequence with a FRET pair used in the incorporation of multiple azobenzene 
moieties (X= Azobenzene units).10 (Reproduced with permission from Asanuma, H.; Liang, X.; Nishioka, 
H.; Matsunaga, D.; Liu, M.; Komiyama, M., Nat. Protoc. 2007, 2, 203-212). 
Komiyama, Asanuma, and co-workers also introduced azobenzenes into specific T7 promoter 
regions for the photoregulation of the transcriptional activity of T7-RNA polymerase (Figure 1-
17a).10, 60 Two azobenzene units were incorporated between the -3 and -4 sites (unwinding region 
loop) and between the -9 and -10 sites (loop-binding region) in the non-template strand of the T7 
promoter, while keeping the template strand intact (Figure 1-17b). Under UV irradiation, which 
leads to the formation of cis-azobenzene, the rate of transcription with T7 RNA polymerase RNAP 
was 10-times faster than that under visible light (trans-azobenzene) as determined by gel 
electrophoresis (Figure 1-17c).10, 60      
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Figure 1-17. a) Photoregulation of transcription by T7-RNA polymerase using azobenzene tethered DNA, 
b) sequence design of the photoresponsive T7 promoter, and c) photoswitching of transcription by T7-RNA 
polymerase as determined by gel electrophoresis (X : azobenzene units).10 (Reproduced with permission 
from Asanuma, H.; Liang, X.; Nishioka, H.; Matsunaga, D.; Liu, M.; Komiyama, M., Nat. Protoc. 2007, 2, 
203-212). 
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The application of azobenzene as photoswitch in the regulation of nucleic acid functions is 
limited by a number of drawbacks. Due to the obvious overlap in the absorption spectra of the two 
azobenzene isomers, complete isomerization is not possible. Further, irradiation by light in the UV 
region may lead to DNA damage. The isomerization of azobenzene in both directions (trans→cis 
and cis→trans) is associated with relatively low quantum yields.55, 61   
1.6.5 Cyclic azobenzenes 
Cyclic, or “bridged”, azobenzene (cAB), was first prepared quite some time ago,62 but 
attracted little attention until very recently, when its potential as a molecular photoswitch was 
discovered by Siewertsen et al. who showed that the photochromic properties of cAB is much 
more favourable for photoswitching compared to plain azobenzene (AB).63 
Compared with AB, the n→π* transition of trans-cAB isomer 48 (Scheme 1-7) is red-shifted, 
but the n→π* transition of the cis-isomer 47 is also significantly blue-shifted, indicating a large 
separation of n-π* bands of the two isomers.63, 38 
The cis-isomer of cAB is switched to the trans-isomer with purple light (370-400 nm) with 
an efficiency >90%, and the latter can be transformed back to the cis-isomer in virtually 
quantitative efficiency with green light (480-550nm) (Scheme 1-7).63 Moreover, due to the ring 
strain, the cis-, but not trans-, isomer is the thermodynamically stable form at room temperature 
by 6-7 kcal/mol,63 which makes cAB photoswitch a useful turn-on system for biological 
applications.   
 
Scheme 1-7. Photoisomerization of cyclic azobenzene.63  
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Figure 1-18 shows the UV/vis spectra of unmodified cyclic azobenzene. The cis-isomer 
exhibits a characteristic absorption band at 404 nm due to its n→π* transition. This band 
disappears upon irradiation with the purple light and a more intense absorption band at 490 nm 
was observed with quantum yields of 72±4% and 50±10% for the forward and backward 
directions, respectively.55, 64  
 
Figure 1-18. UV/vis absorption spectra of cyclic azobenzene 47 and 48. Solid line: (cis or Z)-isomer; dash 
line: (trans or E)-isomer.55 (Reproduced with permission from Zimmerman, G.; L. Y.; Paik, U. J. J. Am. 
Chem. Soc. 1958, 80, 3528-3531)   
In 2012, Yan et al. reported the synthesis of cyclic azobenzene analogue 49 (Figure 1-19) 
through the transformation of 2,2’-dinitrodibenzyl. Upon exposure to purple light, as much as 70% 
of cis-cAB analogue 49 can be isomerized into the corresponding trans-cAB, compared with up 
to 90% isomerization for the unmodified cAB.55  
                                  
Figure 1-19. Structure of cAB-threoninol.55 
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Like linear azobenzene, the photoisomerization property of cyclic azobenzene can also be 
exploited to regulate nucleic acid functions such as hybridization, transcription, and gene 
expression by light. 
1.7 Objectives of this project 
The goal of this project is to first develop a shorter route to synthesize cAB phosphoramidite 
by modifications of the previously reported procedures.55 cAB will then be incorporated into DNA 
sequences by solid phase synthesis with different numbers of cAB units and at different positions 
in the DNA sequence in order to investigate the effect of these modifications on DNA 
hybridization. Impact of cAB on the hybridization affinity of DNA sequences will be investigated 
by measuring the Tms of these modified and unmodified sequences. It is hypothesized that cis-cAB 
will destabilize the DNA duplex to give lower Tm values, while trans-cAB can be accommodated 
by DNA duplex.   
The impact of cAB on the hybridization of DNA will also be explored by FRET experiment. 
In this respect, FAM and the Black Hole Quencher will be incorporated to the 5’- and 3’- of the 
complementary strand and modified DNA sequence respectively. As fluorescent quenching by 
FRET is only possible when the FRET pair is in close proximity, these experiments will provide 
more direct evidence for hybridization. 
 
 
 
 
 
 
29 
  
CHAPTER 2: Site-specific labeling of DNA using Inverse Electron Demand 
Diels-Alder reaction of trans-cyclooctene derivatives and BODIPY-tetrazine 
adduct. 
 
2.1 Inverse Electron Demand Diels-Alder reaction (IEDDA) 
The Diels-Alder (DA) reaction is arguably the most used pericyclic reactions.65 It involves a 
[4+2] cycloaddition between a conjugated diene and a substituted alkene, commonly termed the 
dienophile, to form a substituted cyclohexene system. According to frontier orbital theory, Diels–
Alder reactions can be divided into three subclasses, normal, neutral, and inverse electron demand 
(Figure 2-1).66  
 
Figure 2-1. Frontier orbital model of (a) neutral, (b) normal electron demand and (c) inverse electron 
demand Diels–Alder additions (EDG = electron-donating group, EWG = electron-withdrawing group).66 
Electron-withdrawing groups (EWG) lower the energy of both the HOMO and LUMO on a 
cycloaddend, whilst electron-donating groups (EDG) have the opposite effect. Therefore, normal 
Diels–Alder additions feature electron-rich dienes and electron-poor dienophiles. As a result, these 
reactants show a reduced HOMOdiene–LUMOdienophile separation, compared with the 
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HOMOdienophile–LUMOdiene separation which dominates the reactivity (Figure 2-1b).65-67 In 
IEDDA, dienes are electron-poor while dienophiles are more electron-rich which makes the 
LUMOdiene and HOMOdienophile closer in energy than the HOMOdiene and LUMOdienophile. Thus, the 
LUMOdiene and HOMOdienophile are the frontier orbitals that interact the most strongly (Figure 2-
1c).68 As for neutral Diels–Alder additions, ∆E between the HOMO and LUMO of both reactants 
is similar (Figure 2-1a).66   
Recently, there has been tremendous interest in the use of the click reaction for biological 
labeling. The typical click reaction (Huisgen cycloaddition) involves copper (I)-catalysts, which 
are cytotoxic, for coupling of an azide and terminal alkyne to generate a stable triazole.69 The 
requirement for copper salt in this reaction was circumvented by the work demonstrated by 
Bertozzi and co-workers where ring-strained cyclooctyne derivatives react with organic acids in 
the absence of a catalyst.70, 71 In this regard, the cycloaddition reaction between azides and ring-
strained cyclooctynes has been employed for imaging of cells70 and zebra fish embryos.72 The 
applications of this copper-free click chemistry are somewhat limited by the poor water solubility 
of the cyclooctynes and the difficulty in synthesizing the cyclooctynes in large quantities.73 
2.2 IEDDA between 1,2,4,5-tetrazines and olefins as a potential click reaction  
The presence of  nitrogen in the aza-dienes framework such as 1,2,4,5-terazines (s-tetrazine) 
lower both the HOMO and LUMO energy, making tetrazines ideal substrates for IEDDA 
reactions.65 Additionally, introduction of electron-withdrawing substituents at 3- and 6-positions 
of tetrazine further lower its LUMO, thus accelerating IEDDA, while electron donating 
substituents have a negative effect on reaction rates. Furthermore, dienophiles with electron-rich 
substituents and with a high degree of ring strain are preferred, since the latter can facilitate IEDDA 
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reactions by reducing the activation energy, caused by a raised HOMOdienophile and reduction of the 
distortion energy.66 
Scheme 2-1 shows the mechanism of IEDDA. Tetrazine 50 reacts with a suitable dienophile 
51 to form a highly strained bicyclic adduct 52 which is then rapidly converted to the 
corresponding 4,5-dihydropyridazine 53 upon release of a molecule of dinitrogen.74 1,3-
Prototropic isomerisation, followed by oxidation, leads to the formation of the pyridazine product 
55.75  
              
Scheme 2-1. IEDDA reaction scheme.66 
In 1990, Sauer and coworkers described the reaction kinetics of electron-deficient tetrazines 
with a number of dienophiles and quantitatively demonstrated that strained alkenes such as trans-
cyclooctenes are seven orders of magnitude more reactive than cis-cyclooctenes toward these 
tetrazines.76 Eight years later, Schuster et al.77 demonstrated that un-substituted tetrazine can react 
very rapidly with alkenes and alkynes. It was then until 2008 when IEDDA was demonstrated as 
a potential click chemistry scheme by two independent groups. Fox et al. described the 
bioorthogonal cycloaddition reaction between s-tetrazine and trans-cyclooctene derivatives. The 
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reactions tolerate a broad range of functionality and proceed in high yields in organic solvents, 
water, cell media, or cell lysate. The second-order rate constant for the reaction between 3,6-di-(2-
pyridyl)-s-tetrazine 57 and trans-cyclooctene 56 at 25 °C is 2000 (± 400) M-1 s-1 in 9:1 
methanol/water (Scheme 2-2). This fast reactivity has been employed in protein labeling at low 
concentration78  
 
Scheme 2-2. Fast reactions between 3,6-di-(2-pyridyl)-s-tetrazine and trans-cyclooctene at sub micromolar 
concentrations.78 
The second study by Hilderbrand et al. applied the bioorthogonal tetrazine cycloadditions to 
live cell labeling. They found that benzylamine-modified tetrazine 60 reacts irreversibly with the 
strained dienophile norbornene 61 in aqueous buffer and fetal bovine serum (stain buffer) with 
second-order rate constants of 1.9 and 1.6 M-1 s-1 respectively, forming dihydropyrazine products 
and dinitrogen (Scheme 2-3). 
This chemistry was subsequently used for targeting Her2/neu receptors in live human breast 
cancer cells with a monoclonal antibody modified with a norbornene (“pretargeted antibody”). 
Tetrazines conjugated to fluorophore selectively and rapidly label this pretargeted antibody in the 
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presence of serum, suggesting that this chemistry is a useful strategy for in vivo pretargeted 
imaging.73  
 
 Scheme 2-3. Click reaction between benzylamine-modified tetrazine and strained dienophile norbornene.73  
IEDDA makes a powerful alternative to existing ligation chemistries due to its high reaction 
rate, bioorthogonality and mutual orthogonality with other click reactions. In addition, IEDDA 
cycloaddition of olefins with tetrazines results in irreversible coupling in contrast to many Diels-
Alder reactions, giving dihydropyridazine with releasing of dinitrogen.73 As a result, IEDDA has 
found various applications in labeling nucleic acids, glycans, peptides and proteins, intracellular 
imaging of small molecules, and in vivo imaging as well as modification of cells with 
nanomaterials for clinical diagnostics.79 
2.3  IEDDA features 
2.3.1 Rapid kinetics 
IEDDA reaction kinetics can be tuned by selecting appropriate dienes and dienophiles. For 
example, IEDDA reaction between norbornene 63 (Figure 2-2) and tetrazine proceeds with an 
impressive rate of ~ 1–10 M-1s-1,80 which is considerably faster than other click reactions including 
CuAAC (Cu-catalyzed azide alkyne cycloaddition)81 and SPAAC (strain promoted azide alkyne 
cycloaddition)82 as shown in Table 2-1.66 Replacement of the initially used norbornenes by more 
reactive trans-cyclooctenes 64 speeds up the reaction to 2000 M-1s-1.73 Further chemical 
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modification, for example, enhancement of ring strain of 64 by a condensed cyclopropanyl ring to 
form trans-bicyclo[6.1.0]nonene  65 resulted in the fastest IEDDA example with k2 of up to 
380,000 M-1s-1(Table 2-1).83 Furthermore, the use of cyclopropene derivative 66 as a precursor for 
IEDDA click reaction gave a rate constant of 7 ± 1 M-1s-1 in water/DMSO at 20°C. Although this 
rate constant is comparable to previous bioorthogonal click reactions including IEDDA with 
norborene, it is much slower than the reaction of other strained alkenes with tetrazine, such as 
trans-cyclooctene and its derivatives.84  
             
Figure 2-2. Examples of IEDDA dienophiles.66, 84 
Table 2-1. Typical reaction rates for popular bioorthogonal click reactions.66 
Reaction Reactants Rate [M-1s-1] 
CuAAC Terminal alkyne+azide 10-2-10-4 
Staudinger–Bertozzi 
ligation 
Azide + phosphine 2.2×10-3b 
SPAAC BARACa + azide 1b 
IEDDA 63 + tetrazine 1-10c 
IEDDA 65 + tetrazine 3.8×105d 
a Biarylazacyclooctynone. b measured in CD3CN. c In H2O-MeOH (95 : 5), 21°C. d H2O-dioxane (90 : 10), 
25 °C.  
Very recently, 1,2,4-triazines have been described as a new class of bioorthogonal reagent for 
IEDDA.85 These scaffolds are stable in biological media, in contrast to tetrazines which are prone 
to hydrolysis and side reactions with endogenous thiols. The stability of 1,2,4-triazines can be 
attributed to the high energetics of 1,4-adduct formation and subsequent N2 release transition state. 
As an example, the activation energy for the reactions between methanethiol and 6-phenyl-1,2,4-
triazine 67 and 3-phenyl-1,2,4,5-tetrazine 68 are ~31.5 kcal/mol and 28.6 kcal/mol, respectively. 
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In terms of reactivity, however, 1,2,4-triazines are less reactive than 1,2,4,5-tetrazines with 
activation free energy of 29.3 versus 21.9 kcal/mol for 1,2,4,5-tetrazines. Figure 2-3 shows the 
predicted relative rate constants for tetrazine or triazine cycloaddition with 3-
carbamoyloxymethyl-1-methylcyclopropene, norbornene, or trans-cyclooctene, in water at 25 °C. 
6-Aryl-1,2,4-triazine 67 react efficiently with trans-cyclooctene with a rate constant of 8.3× 10-2 
M-1 s-1, which is much slower than that of 1,2,4,5-tetrazine 68, with a rate constant of ~4.9× 103 
M-1 s-1, while triazine remains inert to other bioorthogonal scaffolds.85 
 
Figure 2-3. DFT-computed activation free energies (kcal/mol) and predicted relative rate constants (in 
parenthesis) for tetrazine or triazine cycloaddition with 3-carbamoyloxymethyl-1-methylcyclopropene, 
norbornene, or trans-cyclooctene, in water at 25 °C.85 
2.3.2 Bioorthogonality and mutual orthogonality with other click reactions 
A major advantage of IEDDA ligations over other click reactions such as CuAAC is that they 
do not require a metal catalyst making IEDDA highly suitable for biological applications.86   
The ability to control chemical reactivity and selectivity, especially in chemically complex 
environments, is one of the most appealing features of IEDDA click chemistry.87 The mutual 
orthogonality of IEDDA click chemistry, as shown in pathway a in Figure 2-4, with other click 
reactions, such as azide-alkyne click chemistry and thiol-ene click chemistry, as shown in pathway 
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b in Figure 2-4, enables the simultaneous multiple selective labeling reactions to connect complex 
functionalities in a facile fashion without the need for protecting groups.66 This “one-pot approach” 
is very useful in many applications in the field of chemical biology, drug discovery,88 and 
macromolecular chemistry.89 However, there are some cyclooctynes which are prone to undergo 
both IEDDA and SPAAC c and d (Figure 2-4) , therefore, these two reactions cannot be performed 
simultaneously.66   
 
Figure 2-4. Suitable pairs for mutually orthogonal azide-alkyne/IEDDA click chemistry.66 
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2.4 Tetrazine probes 
Since the unmodified tetrazines could not be applied directly to bioconjugation, as they were 
not stable in water,90 a considerable number of different unsymmetric and symmetric tetrazine 
analogues with various functionalities have been prepared.91 A straightforward two-step procedure 
for synthesizing tetrazines involves the reaction of nitriles 69 or analogues, such as nitrile imines 
or aldehydes with hydrazine (both anhydrous and hydrated hydrazine may be used) (Scheme 2-
4a). For unsymmetrically substituted tetrazines, formamidine acetate 72 is used as a reagent 
(Scheme 2-4b).91 The resulting dihydrotetrazines 70 and 73 can be further oxidized into the fully 
aromatic tetrazines 71 and 74 by HONO. Either sulfur74 or Lewis acids such as nickel triflate or 
zinc triflate can be used as catalysts in this reaction. High yields can be obtained by using a pressure 
tube at higher temperature.90  
 
Scheme 2-4. Synthetic strategies for tetrazines using a) hydrazine or b) formamidine acetate as reagents.92   
Another important route toward the preparation of differently functionalised tetrazines is 
through nucleophilic aromatic substitution (SNAr)
65, 90, 91 of precursors such as 3,6-bis(3,5-
dimethyl-1H-pyrazol-1-yl)-s-tetrazine 75,93 and 3,6-dichloro-s- tetrazine 7694 (Scheme 2-5).  
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Scheme 2-5. General approach for the nucleophilic substitution of s-tetrazine.91 
The color of most tetrazines ranges from orange to red due to the weak n→π* transition 
excited by light with wavelength around 520 nm.91 In addition, some suitably substituted tetrazines 
are fluorescent, however, the fluorescence of these tetrazine analogues are weak in general due to 
the low molar extinction coefficient of the associated absorption band (ca. 1000 M-1cm-1).95 
  Since tetrazines absorb light in the visible region, they are considered as chromophores, thus 
they can act as quenchers towards a series of fluorophores96 based on the resonance energy transfer 
(RET) theory as supported by the studies of Dumas-Verdes et al.97 and Weissleder et al.98 On the 
other hand, upon reaction of tetrazines with an IEDAA partner, fluorescence can be restored, thus 
providing excellent “turn-on” probes with minimal background signal in biomolecule labeling 
experiments. Figure 2-5 shows examples of some tetrazine probes which have been used for 
IEDDA cycloadditions. 
Figure 2-5. Examples of symmetrical and unsymmetrical aromatic s-tetrazines used for IEDDA.99,100  
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Several factors have to be taken into considerations regarding the quenching mechanism.96 
The spectral overlap between the emission of the fluorophore and the absorption of the tetrazine, 
and the close proximity of the fluorophore and the quencher results in a through-space energy 
transfer mechanism which is generally known as a florescence resonance energy transfer (FRET) 
(Figure 2.6a).96, 101 If the fluorophore is connected to the acceptor via electronically conjugated 
linkers, the energy transfer in such a system occurs through-bonds (TBET) and through-space 
(FRET) (Figure 2-6b).96, 97, 101  
  
Figure 2-6. a) Through-space and b) through-bond and through space energy transfer cassettes.101  
When tetrazine undergoes IEDDA reaction, it is converted to a (dihydro)pyridazine derivative. 
This reaction is accompanied by a drastic change in electronic and spectroscopic properties. 
Therefore, the fluorescence is restored.96  
Another possible mechanism for the quenching process results from photoinduced electron 
transfer (PET) between the fluorophore and tetrazine. Before IEDDA reaction, the HOMOtetrazine 
lies higher in energy than that of the HOMOflorophore, thus an electron from HOMOtetrazine can be 
transferred to HOMOflorophore. This process competes with radiative decay of the excited 
fluorophore to the ground state, thus diminishing the fluorescence. Reaction of tetrazine through 
IEDDA makes HOMOtetrazine lower than HOMOphrorophore, preventing electron transfer, thus 
fluorescence is restored (Figure 2-7).102  
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Figure 2-7. Energy level diagrams illustrating PET from the frontier molecular orbital perspective.102  
Weissleder and coworkers designed a series of tetrazine-fluorophore probes where the 
fluorescence of these molecules was efficiently quenched by tetrazine via FRET, with up to a 20-
fold enhancement in fluorescence after destruction of the tetrazine upon IEDDA cycloaddition. 
For instance, the green-emitting tetrazine dye, tetrazine-BODIPY FL 85 (Figure 2-8a) showed 
fluorescence enhancement of approximately 15-fold upon cycloaddition.98, 103  
In a separate study, Chin et al. demonstrated that tetrazines can also quench near-IR-emitting 
fluorophores such as tetramethylrhodamine 87 (Figure 2-8b). However, the fluorescence 
enhancement was only about 5-fold due to the large separation in space between the FRET pair.80  
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Figure 2-8. Tetrazine “turn-on” probes. a) BODIPY FL–tetrazine conjugate and b) tetramethylrhodamine-
tetrazine conjugate.103  
FRET efficiency can be increased dramatically by reducing the distance between tetrazine and 
the fluorophore. Moreover, the close proximity of the FRET pair may allow for other quenching 
pathways, such as through-bond energy transfer (TBET).101, 103 To raise the possibility of the latter 
pathway, the conjugated linker between tetrazine and the fluorophore should not be flexible, and 
must prevent tetrazine and the fluorophore to be co-planar, otherwise the system would behave as 
a single conjugated dye.101 The first explanation of this phenomenon was provided by Carlson et 
al. who synthesised a series of virtually non-fluorescent BODIPY-tetrazine conjugates 88, 89, and 
90 (Figure 2-9), where the tetrazine was attached to the BODIPY core via a rigid phenyl linker.104 
BODIPY-tetrazine conjugate 88 exhibits a 90 degree rotation between the BODIPY and tetrazine 
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ring which prevents pi-system conjugation and increases the efficiency of the FRET quenching. 
Indeed, reaction of 88 with trans-cyclooctenol in water gave a turn-on ratio of 900- fold.  
 
Figure 2-9. BODIPY-tetrazine probes connected with rigid linkers.104  
Moving the attachment position of the tetrazine from para- to meta- on the phenyl ring, such 
as in conjugate 89, exhibited even greater turn-on ratio, e.g. 1600-fold in water.104 To demonstrate 
that TBET was operative in the quenching, BODIPY-tetrazine conjugate 90 was synthesized. In 
this derivative, the BODIPY and tetrazine groups were arranged such that their transition dipoles 
are nearly perpendicular which prevents efficient FRET. In addition, conjugation of the phenyl 
linker was minimized by the ortho-methyl group. Surprisingly, a 120-fold enhancement in 
fluorescence was still observed upon reaction of 90 with trans-cyclooctenol, suggesting that FRET 
is not the only quenching pathway in these conjugates, and tetrazine-TBET quenching mechanism 
may be taken into consideration. PET quenching mechanism was ruled out as the fluorescence 
emission intensity of these compounds was found to be independent of solvent polarity. After 
cycloaddition, the fluorescence quantum yields of these compounds reached up to 0.8, indicating 
that quenching was fully relieved.  Excellent signal intensity, reduced background fluorescence 
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and no requirement for washing steps in the labeling process make BODIPY-terazine conjugates 
very attractive molecules for biological applications. Indeed, these compounds were successfully 
applied for imaging trans-cyclooctene-functionalized antibodies on both fixed and live cells.103, 104   
The approach described above was expanded to multicolor imaging.103 Coumarin-tetrazine 
conjugates, such as 91, were designed (Figure 2-10).105 In these compounds, transition dipoles of 
the coumarin fluorophore and the tetrazine align significantly to maximize contribution from 
FRET in addition to TBET, resulting in an up to an impressive 11000-fold enhancement in 
fluorescence to final quantum yields of 0.5 upon tetrazine ligation. These compounds, named 
HELIOS probes, were used for efficient detection of a variety of trans-cyclooctene-functionalized 
molecules in fixed and live cells.103, 105  
 
Figure 2-10. Cumarin-tetrazine probe.105  
2.5 IEDDA for site-specific labeling of nucleic acids 
Labeling of oligonucleotides (RNA or DNA) with a molecule of interest (e.g., a fluorescent 
dye or affinity tag) helps in understanding their functions. Recently, IEDDA between tetrazines 
and olefins has been used for this application.  
In 2010, Jȁschke et al. introduced norbornene moieties as dienophiles into DNA sequences at 
both terminal and internal positions during solid-phase synthesis, and the deprotected oligomers 
are then conjugated with water-stable tetrazine (Scheme 2-6).106 In this study, when norbornene 
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moiety 94 was introduced to 19-mers ODN as shown in Figure 2-11, followed by treatment with 
equimolar amounts of tetrazine probe 95 at room temperature, 50% conversion was obtained after 
only 12 min. Higher conversion (up to 90%) was obtained by increasing the reaction time to 3 h 
with a rate constant ~ 20 ± 2 M-1 s-1.106 
 
Scheme 2-6. General scheme for IEDDA between norbornene modified DNA and tetrazine derivative.106   
 
Figure 2-11. Norbornene building block 94 and tetrazine probe 95 for fluorescent labeling of DNA.106  
This approach was further expanded to RNA molecules via both chemical and enzymatic 
routes.107 First, a 5’-norbornene-modified 19mer RNA 96 was synthesized by solid phase synthesis 
using a norbornene phosphoramidite.106 After 96 was incubated with a dansyl-modified tetrazine 
97 at room temperature for 90 min, ~90% of the RNA was converted to the Diels-Alder product 
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98 (Scheme 2-7a) as determined by LC-MS analysis.107 In addition, an “initiator” 99, i.e. guanosine 
modified with norbornene at the 5’-position, was synthesized108 in order to label RNA molecules 
that are enzymatically transcribed. T7 RNA polymerase efficiently transcribed the DNA template 
using a defined promoter, having a guanosine nucleotide as +1 base, which is the transcription 
start site(Scheme 2-7b).109 Upon IEDDA, conversions of norbornene-labelled RNA to IEDAA 
product were found to be comparable to those obtained for chemically modified RNA and the 
labeling efficiency was found to depend on both the incubation time and the excess of dansyl-
tetrazine reagent.107    
Scheme 2-7. a) IEDDA reaction of a norbornene-modified RNA with Dansyl-modified tetrazine and b) 
incorporation of the initiator nucleotide into transcribed RNA by T7 RNA polymerase.107    
A successful combination of CuAAC and IEDDA for simultaneous site-specific double-
labeling of DNA oligonucleotides in a one-pot reaction has been reported.83 In this study, three 
different trans-cyclooctene-based alcohols were synthesized as dienophiles moieties. These 
moieties include two diastereomers of (E)-cyclooct-4-enol and endo-(E)-bicyclo[6.1.0]non-4-en-
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9-yl methanol, which were converted into corresponding phosphoramidite 101, 102 and 103 
respectively (Figure 2-12).83 Doubly modified oligonucleotides were synthesized by introducing 
one of the reactive dienophiles at 5’-end, while the alkynyl residue was attached to an internal 
position. CuAAC and IEDDA reactions were carried out simultaneously (by incubation of the 
oligonucleotide with Alexafluor-594 azide, CuSO4, tris-(benzyltriazolylmethyl)amine (TBTA), 
sodium ascorbate, and tetra-methylrhodamine-tetrazine (TAMRA-tetrazine) 104 as shown in 
Scheme 2-8. Neither the primary mass spectra nor the MS/MS spectra indicated the presence of 
multiply or cross-functionalized fragments that would indicate cross-reactivity. In addition, 
IEDDA proceeded with rate constants up to 380 000 M−1 s−1 which are ~8 orders of magnitude 
more reactive than CuAAC reactions.83  
 
 
Figure 2-12. Trans-cyclooctene-derivative phosphoramidies 101, 102, 103 and TAMRA-tetrazine 104 
used for site specific one-pot dual labeling of DNA.83  
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Scheme 2-8. Double modification of a DNA oligonucleotide by simultaneous IEDDA and CuAAC 
reaction.83  
In 2014, Royzen et al. reported the site-specific fluorescent labelling of RNA using a cytidine 
triphosphate (CTP) analogue 107 (Figure 2-13) derivatized with a trans-cyclooctene at the 5-
position of the cytosine to minimally alter the electrostatics of cytosine, which is important to 
preserve enzymatic recognition.110, 111 This modified CTP was incorporated into an RNA strand 
by in vitro transcription using DNA template with the sequence: 5’-
ACAAACACCATTGTCACACTCCACCTGTCTC-3’. The transcription generates the RNA 
product 5’-GGGAGACAGGUGGAGUGUGACAAUGGUGUUUGU-3’ where trans-
cyclooctene modified cytodine is incorporated at the two underlined positions. The transcription 
efficiency of the CTP analogue was calculated to be 60 ± 5%, suggesting that this modification 
does not disrupt the recognition of the nucleotide by T7 RNA polymerase.110 Bioorthogonal 
reactions of the modified RNA with fluorescein-labelled tetrazine 108 achieved 60% conversion. 
This approach could be potentially used for fluorescent labeling of any RNA molecules. Further, 
it could also allow for in vivo imaging of nucleic acids of interest in real time.110 
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Figure 2-13. The bio-orthogonal pair utilized for site-specific fluorescence labelling of RNA.110 
2.6 Objectives of this project 
The main goal of this project is the site-specific fluorescent labeling of DNA oligonucleotides 
by IEDDA cycloaddition of trans-cyclooctene derivatives and BODIPY-tetrazine 89. The 
attractive features of this reaction have been discussed previously in this chapter. Trans-
cyclooctene derivatives will be introduced through an alkyne linker to the 5-position of 2’-
deoxyuridine through the Sonogashira coupling reaction, followed by conversion to corresponding 
phosphoramidites. Using solid phase DNA synthesis, these phosphoramidites will be incorporated 
into DNA sequences for labeling with BODIPY-tetrazine 89 via the IEDDA.   
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CHAPTER 3: Results and discussions  
(Photoregulation of DNA functions by cyclic azobenzene derivatives) 
 
3.1 Synthesis of cyclic azobenzene phosphoramidite 
Cyclic azobenzene phosphoramidite monomer was synthesised by following the previously 
reported procedure55, 112 with some modifications. First, cyclic azoxybenzene 110 was synthesized 
in moderate yields (62%) (Scheme 3-1) by the treatment of 2,2’-dinitrodibenzyl 109 with lead 
powder and sodium carbonate. Under this condition, this reaction was completed in 24 h, even on 
larger scales (e.g. 20 g of dinitrodibenzyl) and without the need for addition of extra portions of 
lead powder. This transformation was previously carried out in the presence of triethylammonium 
acetate buffer55 which was quite often difficult to reproduce, especially on larger scales. 
 
Scheme 3-1. Reagents and conditions: (a) Pb, Na2CO3, MeOH, 62%; (b) Br2, CH3COOH, 69%; (c) PCl3, 
dry benzene, 50%; (d) CuCN, dry DMF, 61%; (e) KOH, H2O, EtOH, 96%.  
 
Electrophilic aromatic bromination of cyclic azoxybenzene 110 with bromine in the presence 
of acetic acid gave the corresponding bromoazoxybenzene 111 in 69% yield. The latter compound 
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underwent deoxygenation when treated with freshly distilled phosphorus trichloride in dry benzene 
to give the corresponding bromoazobenzene 112 in 50% yield. 
Cyanoazobenzene 113 was obtained in 61% yield by treating bromoazobenzene 112 with 
copper (I) cyanide in dry dimethylformamide. Subsequent hydrolysis of nitrile group of 113 under 
alkaline conditions, i.e. potassium hydroxide solution in aqueous ethanol, gave the corresponding 
carboxylic acid 114 in 96% (Scheme 3-1).  
The cyclic azobenzene carboxylic analogue 114 was then coupled with D-threoninol 115 using 
dicyclohexylcarbodiimide (DCC) as an activator in the presence of N-hydroxysuccinimide (NHS) 
to give D-threoninol-linked cyclic azobenzene amide 116 in 90% yield (Scheme 3-2). This 
compound was subsequently treated with dimethoxytrityl (DMTr) chloride in dry pyridine to give 
the corresponding DMTr-protected compound 117 in 83% yield.  
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Scheme 3-2. Reagents and conditions: (a) DCC, NHS, DMF, 90%; (b) DMTr-Cl, pyridine, 83%; (c) (2-
cyanoethyl) -N,N-diisopropylphosphochloridite, DIPEA, THF,  72%; (d) solid phase DNA synthesis. 
Finally, cyclic azobenzene phosphoramidite 118 was synthesized in 72% yield by treating 
DMTr-protected D-threoninol-linked cyclic azobenzene derivative 117 with the phosphitylating 
reagent (2-cyanoethyl)-N,N-diisopropylphosphochloridite in the presence of N,N-diisopropyl 
ethylamine (DIPEA, or Hünig’s base) in freshly distilled tetrahydrofuran (THF) (Scheme 3-2). 
Figure 3-1 shows the 31P NMR spectrum of cyclic azobenzene phosphoramidite 118 as a mixture 
of two diastereomers.   
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Figure 3-1. 31P NMR spectrum of cyclic azobenzene phosphoramidite 118. 
Cyclic azobenzene phosphoramidite 118 was processed following the standard procedure used 
for drying phosphoramidite, and then shipped to Dr. Richard Pon’s DNA lab (University of 
Calgary) for incorporation into DNA sequences using solid phase synthesis.   
3.2 Synthesis of cyclic azobenzene-modified oligonucleotides 
Using cyclic azobenzene phosphoramidite monomer 118 as a building block, a 20-mer DNA 
sequence was modified by the insertion of cAB-Thr at up to four different positions (Table 3-1). 
The standard ABI 0.2 μmol phosphate protocol was modified as follows: 10 min coupling at cAB 
position and 5 min coupling at the base immediately after cAB because the hydroxyl group on 
cAB phosphoramidite is quite shielded by cAB group which will interfere with the next coupling.  
All the modified sequences were attached to Black Hole Quencher-1 (BHQ-1, as shown in 120 in 
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Figure 3-2) at the 3’-end while fluorescein (6-FAM, as shown in 121 in Figure 3-2) was attached 
to the 5’-termini of the complementary strand (Figure 3-2). This FRET (Fluorescence Resonance 
Energy Transfer) pair will be used to evaluate the ability of these modified sequences to hybridize 
using the FRET technique. After solid phase synthesis, the products were deprotected and purified 
by gel electrophoresis. The optical density (OD260) of the purified DNA sequences was quantified 
at 260 nm. DNA concentration was subsequently estimated using the following equation:113 
1 OD = 33 μg/ml solution of ssDNA 
Table 3-1. Cyclic azobenzene-modified oligonucleotide; where X= cAB phosphoramidite. 
a Deprotected by incubation with aqueous dimethylamine-concentration ammonium hydroxide (1:1, v/v) at 
60°C for 20 min. bDeprotected by incubation with concentrated ammonium hydroxide at 55°C for 15 h. 
cM.W. of neutral species. dMass deconvoluted for neutral species. 
 
Oligo 
Name 
Sequence 5’ to 3’ 
Scale 
(µmol) 
OD 260 
MW 
Calculatedc 
MW 
Foundd 
AB0 CTTTAAGAAGGAGATATACC-BHQ-1 1.0 56.8 6703.6 6703.8 
FAM FAM-GGTATATCTCCTTCTTAAAG 1.0 27.7 6620.2 6619.8 
AB1 CTTTAAGAAGXGAGATATACC-BHQ-1 0.2 9.7
a 7104.9 7105.5 
AB1-1 CTXTTAAGAAGGAGATATACC-BHQ-1 0.2 5.5
b 7104.9 7103.5 
AB1-2 CTTTAAGAAGGAGATATAXCC-BHQ-1 0.2 17.6
a 7104.9 7104.0 
AB2 CTTTAXAGAAGGAGATXATACC-BHQ-1 0.2 2.7
b 7506.3 7505.0 
AB2-1 CTXTTAAGAAGXGAGATATACC-BHQ-1 0.2 1.9
b 7506.3 7506.0 
AB2-2 CTTTAAGAAGXGAGATATAXCC-BHQ-1 0.2 10.9
a 7506.3 7505.5 
AB3 CTTTAXAGAAGXGAGATXATACC-BHQ-1 0.2 4.0
a 7907.7 7907.0 
AB4 
 
CTTTXAAGAXAGGAXGATAXTACC-BHQ-1 0.2 6.1a 8309.0 8308.5 
54 
  
 
Figure 3-2. Structures of BHQ-1 120 and 6-FAM 121.  
It is clear from the OD values of the purified oligonucleotides that the synthesis yields of some 
cAB-modified DNA sequences were quite low in general. This is particularly the case when cAB-
Thr is incorporated into multiple positions of oligonucleotides. It is possible that the low overall 
yields are due to cleavage of the amide bond in cAB-Thr during deprotection under basic 
conditions (as shown in 119, Figure 3-3a). This cleavage is also dependent on deprotection 
conditions, as deprotection using a AMA solution (aq. NH4OH-methylamine 1:1, v/v) gave higher 
yields (as can be seen in Figure 3-3b), probably due to the much shortened deprotection time, i.e. 
20 min at 60°C as compared with heating overnight at 55°C in aq. NH4OH solution.  
55 
  
a)                                                                  b)          
 
   
 
  
Figure 3-3. a) Structure 119 shows the cleavage position, b) lane 1) CTT TAA GAA GGA GAT ATA XCC 
deprotected by AMA at 60°C for 20 min; lane 2) 20-mer control; lane 3) CTX TTA AGA AGG AGA TAT 
ACC deprotected by aq. ammonium hydroxide at 55°C o/n; lane 4) 20-mer control.  
The hypothesized cleavages of amide bond is also supported by the differences seen in the 
trityl assay and mass spectroscopic data of the AB1 sequence. The trityl assay for the synthesis of 
AB1 (Figure 3-5) shows that the coupling efficiency of cyclic azobenzne was reasonably good 
(>92%); however, the mass spectrum of HPLC-purified AB1 (Figure 3-4) shows that in addition 
to the desired sequence, which has a molecular weight of 7105 Daltons, there is major truncated 
sequence with a molecular weight of 3590 Daltons, which corresponds to the cleavage fragment 
124 shown in Scheme 3-3. Thus, it can be assumed that if cyclic azobenzene is cleaved at the 
amide bond during deprotection, the resulting NH2 can attack the phosphodiester bond, leading to 
chain cleavage (Scheme 3-3).    
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Mass spec (ESI-) 
 
 
 
 
 
 
 
 
 
Figure 3-4. Mass spectroscopy of AB1 (5’-CTTTAAGAAGXGAGATATACC-3’BHQ-1). 
 
 
 
 
 
 
 
Number of base 
Figure 3-5. Trityl assay of AB1 (5’-CTTTAAGAAGXGAGATATACC-3’BHQ-1) synthesis. 
 
Scheme 3-3. The postulated mechanism for the amide bond cleavage of cAB phosphoramidite. 
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To improve the yield of the synthesis, AMA solution was used for deprotecting of AB1, AB1-
2, AB2-2, AB3 and AB4 resulting in better yields compared to the other sequences. In future 
experiments, combination of ultramild phosphoramidites114, 115 and the Q-linker116 will be used for 
the synthesis of cAB-modified oligonucleotides, as cleavage from solid support and deprotection 
can be accomplished under very mild alkaline conditions, i.e. incubation with aqueous ammonium 
hydroxide for 2 h at room temperature. 
3.3 Thermal back isomerizatiom studies of trans-cyclic azobenzene 
Thermal back isomerization experiments were performed using UV-vis spectrophotometer at 
different temperatures (25-95°C), in order to investigate the stability of trans-cAB at elevated 
temperatures. First, the cis-cAB 47 which is the thermodynamically stable isomer, was isomerized 
to trans-cAB 48 in DMSO at 25°C by exposure to purple light (395 nm) for 2 h. The absorbance 
of the isomerized products was recorded in the range of 350-650 nm. Then the absorption spectra 
were recorded with every 10°C increase in temperature. The sample was kept for ~5 min prior to 
next measurement. This experiment was performed twice, one with samples exposed to light (395 
nm) throughout the experiment (Figure 3-6a), and another with light off (Figure 3-6b). It is clear 
from both graphs that the light does not have measurable effects and that temperatures dominate 
the back isomerization process. 
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a)                                                                          b) 
 
 
 
 
 
 
 
Figure 3-6. UV-vis spectra of cAB 47 in DMSO (1.5 mg/1.5 ml), a) thermal back isomerization of trans-
cAB with the purple light (395 nm) on, b) the same experiment but the light off.   
Thermal back isomerization experiment was performed also at fixed temperatures 25, 37 and 
55°C. While Figure 3-7c suggests that trans-cAB completely isomerizes back to the cis-form in 
about 100 min at 55°C, this process takes over 100 and 24 h at 25 and 37°C, respectively (Figure 
7-3 a, b)  
Figure 3-7. Back-isomerization of trans- to cis-cAB in DMSO (1.5 mg/1.5 ml) at a) 25°C, b) 37°C, and c) 
55°C. 
From these observations, it can be concluded that the back isomerization process of trans-
cAB is temperature-dependent. These results are useful in experimental design and interpreting 
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the results of the melting temperature (Tm) measurement of the cAB-modified DNA duplexes, as 
Tm measurement requires heating samples to elevated temperatures, e.g. 95°C. 
3.4 Photoregulation of DNA melting temperature (Tm) 
Tm is defined as the temperature at which half of a DNA duplex is denaturated. In order to 
determine the ability of cAB-tethered DNA sequences to hybridize, Tms of these modified 
sequences in the presence of the complementary strand were measured and compared with the 
unmodified duplex. It is hypothesized that cis-cAB will disturb the DNA duplex due to its non-
planarity, as a result, lowering the Tm values; while trans-cAB will intercalate into and stabilize 
DNA duplexes, leading to Tm values higher than the corresponding dsDNA with cis-cAB. 
The final concentration for each component used in this experiment is shown in (Table 3-2). 
For annealing the strands, samples were placed in the heating block at 95°C for ~3-5 min and then 
cooled down slowly to room temperature, which typically took 45-60 min. 
Table 3-2. Final concentrations for each component used for the melting temperature experiments.  
Component Concentration 
FAM-DNA 2 µM 
BHQ-1-DNA 2 µM 
Tris-HCl (pH 8.0) 10 mM 
NaCl 50 mM 
 
The Tm measurement was performed using UV-vis spectrophotometer equipped with 
temperature control. It can be concluded from the Tm results (Table 3-3) that there is a decrease by 
5-8°C in the Tm values for each cAB unit incorporated into the DNA sequence when cAB exists 
in the cis-form. For example, incorporation of one cAB to the middle of the sequence (AB1) lowers 
the Tm value by 5°C to 43°C as compared to 48°C for the unmodified one (AB0). Going from AB1 
to AB4, which contains four cAB units, a 27°C decrease in the Tm value can be seen, suggesting 
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that the more cAB units incorporated, the lower the Tm value. All of these results are in agreement 
with what was expected.  
For AB1-1 and AB1-2 where cAB is incorporated to a position close to 5’- and 3’-end of the 
BHQ strand, respectively, the Tm values do not significantly differ from that of AB1, suggesting 
that the way that cAB affects DNA hybridization might be independent of the position of 
incorporation. Similar results were found for AB2-1 and AB2-2. 
As trans-cAB is not stable thermodynamically, as it was shown previously in this chapter, it 
was not possible to perform the same experiment to measure the Tm values of the DNA duplexes 
containing trans-cAB.    
Table 3-3. The melting temperature (Tm) values for cAB-modified DNA Duplexes.   
Name Duplexes 
Tm°Ca 
(cis-cAB) 
AB0-FAM 
CTTTAAGAAGGAGATATACC-BHQ-1       
GAAATTCTTCCTCTATATGG-FAM 
48 
AB1-FAM 
CTTTAAGAAGXGAGATATACC-BHQ-1 
GAAATTCTTC  CTCTATATGG-FAM 
43 
AB1-1-FAM 
CTXTTAAGAAGGAGATATACC-BHQ-1 
GA   AATTCTTCCTCTATATGG-FAM 
44 
AB1-2-FAM 
CTTTAAGAAGGAGATATAXCC-BHQ-1                  
GAAATTCTTCCTCTATAT  GG-FAM 
42 
AB2-FAM 
CTXTTAAGAAGGAGATATAXCC-BHQ-1 
GA   AATTCTTCCTCTATAT  GG-FAM 
36 
AB2-1-FAM 
CTXTTAAGAAGXGAGATATACC-BHQ-1 
GA   AATTCTTC  CTCTATATGG-FAM 
37 
AB2-2-FAM 
CTTTAAGAAGXGAGATATAXCC-BHQ-1 
GAAATTCTTC   CTCTATAT  GG-FAM 
36 
AB3-FAM 
CTTTAXAGAAGXGAGATXATACC-BHQ-1 
GAAAT   TCTTC   CTCTA  TATGG-FAM 
28 
AB4-FAM 
 
CTTTXAAGAXAGGAXGATAXTACC-BHQ-1 
GAAA  TTCT   TCCT    CTAT   ATGG-FAM 
21 
           aTemperature ramp 1°C/min. 
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3.5 Circular Dichroism (CD) experiment 
CD measurement was performed for AB0 and modified DNA duplexes in order to study the 
secondary structure of cAB-modified DNA duplexes, as CD of nucleic acids is commonly used to 
provide a signature for their secondary structures. The common features of B-DNA duplexes 
include the following, a positive band at 275 nm, a negative band near 250 nm, and a cross-over 
point (from positive to negative intensity) at 260 nm. 
Concentrations of each component used for CD measurement are shown in Table 3-4. Strands 
are annealed following the same procedures described previously for Tm measurement in section 
3.4. 
Table 3-4. Final concentration for each component used for the CD experiment.  
Component Concentration 
FAM-DNA 1.6 µM 
BHQ-1-DNA 1.6 µM 
Tris-HCl (pH 8.0) 10 mM 
NaCl 50 mM 
 
The results of this experiment were in agreement with those of Tm experiments, that is, 
incorporation of cAB units into DNA destablizes the DNA secondary structure (Figure 3-9). In 
this respect, AB0 showed the typical CD signature that corresponds to B-form duplexes. The 
typical CD transition bands are weakened with the increase in the number of cAB incorporated 
into the sequences. AB4, for example, which has a Tm below room temperature (21°C), the 
intensities of the transitions are much weaker than those of AB0 (Figure 3-8).  
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Figure 3-8. CD profiles for unmodified and cAB-modified DNA duplexes. 
3.6 Fluorescence Resonance Energy Transfer (FRET) experiment 
The possibility for trans-cAB to be accommodated in DNA duplexes was assessed by 
fluorescence Resonance Energy Transfer (FRET) experiments. Thus, FAM and 9 AB sequences 
(AB0-AB4) were individually prepared using the conditions summarized in Table 3-5. Strands 
were annealed following the same procedures described previously for Tm measurement in section 
3.4. 
Table 3-5. Final concentration for each component used for the FRET experiment. 
Component Concentration 
FAM-DNA 80 nM 
BHQ-1-DNA 120 nM 
Tris-HCl (pH 8.0) 10 mM 
NaCl 50 mM 
 
The Fluorescence of each duplex was measured when cAB exists in the cis-form. The results 
are shown in Figure 3-9 which represent the average of two independent experiments.    
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Figure 3-9. FRET experiment results for cAB-modified DNA duplexes where cAB exists in the cis-form.  
It is clear from these results that the fluorescence intensity observed for the DNA duplexes is 
dependent on the number of cAB units that are incorporated, i.e. the more cis-cAB units attached 
to the DNA template, the higher the fluorescence intensity at 515 nm, which is a result of duplex 
destabilization, leading to the spacial separation of the FRET pair (fluorescein–Black Hole 
Quencher pair). 
Then, the eight cAB-modified duplexes (AB1-AB4) were individually subjected to 
isomerization by exposure to purple light at 395 nm for 2 h, and the fluorescence of each duplex 
was determined as shown from Figure 3-10 to Figure 3-17.  
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Figure 3-10. FRET experiment results for AB1-FAM duplex.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-11. FRET experiment results for AB1-1-FAM duplex.  
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Figure 3-12. FRET experiment results for AB1-2-FAM duplex.  
 
 
Figure 3-13. FRET experiment results for AB2-FAM duplex.  
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Figure 3-14. FRET experiment results for AB2-1-FAM duplex.  
  
 
Figure 3-15. FRET experiment results for AB2-2-FAM duplex.  
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Figure 3-16. FRET experiment results for AB3-FAM duplex. 
 
 
Figure 3-17. FRET experiment results for AB4-FAM duplex.  
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The FRET quenching of the FAM/BHQ-1 FRET pair was used as an indication for the degree 
of hybridization, which is measured by equations (1 for cis-cAB) and (2 for trans-cAB) (F.I.: 
fluorescent intensity), where (FAM-ss) is the FAM single strand, (ABx-FAM) is cAB-modified 
DNA duplexes and (AB0-FAM) is the unmodified duplex. The values for each of the duplexes are 
summarized in Table 3-6. 
  
                                                                                                              (1)  
 
 
                                                                                                           (2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
69 
  
Table 3-6. Fluorescent quenching as a measure of degree of hybridization for the DNA duplexes 
incorporating cAB. 
Entry Duplex 
%Quenching 
(cis-) 
%Quenching 
(trans-) 
%Difference 
(trans-cis) 
1 AB0-FAM - - - 
2 AB1-FAM 90 95 5 
3 AB1-1-FAM 90 106 16 
4 AB1-2-FAM 83 104 21 
5 AB2-FAM 63 90 27 
6 AB2-1-FAM 65 94 29 
7 AB2-2-FAM 58 87 29 
8 AB3-FAM 37 73 36 
9 AB4-FAM 22 58 36 
 
As Table 3-6 shows, compared with cis-cAB, trans-cAB is better accommodated in DNA 
duplexes. AB3 and AB4 duplexes gave the highest difference values of 36%, indicating that the 
more cAB unit incorporated, the bigger the difference in fluorescence quenching between duplexes 
with cis- and trans-cAB and the better the system for the photoregulation of DNA hybridization. 
Although this difference might appear to be moderate, it should be borne in mind that the cis-trans 
isomerization in cAB will likely to be useful as a “turn-on”, instead of a “turn-off”, switch. 
It is also worth mentioning that AB1-2-FAM system gave better FRET results than its 
analogues AB1-FAM and AB1-1-FAM.  As cAB is positioned closer to the quencher, AB1-2-FAM 
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system gave 21% difference in fluorescence quenching between cis- and trans-duplexes which is 
5 and 16% higher than that of AB1-1-FAM and AB1-FAM, respectively. These results suggest that 
AB1-2-FAM system has more impact on the hybridization affinity than its analogues although these 
results are not in agreement with those obtained from Tm experiment which suggest the this process 
is independent of cAB-position. This discrepancy can be explained in that Tm represents the overall 
structure of the DNA duplex, while FRET experiments results are more dependent on the spacial 
separation of the FRET pair.   
3.7 Conclusions and future work 
cAB-Thr was successfully incorporated into oligonucleotides (Figure 3-18). Tm results 
showed a decrease by 5-8°C in the Tm values for each cAB unit incorporated into the DNA 
sequence when cAB exists in the cis-form. However, it was not possible to measure the Tm for 
trans-isomer, as trans-cAB is not stable thermally. In addition, the typical CD transition bands are 
weakened with the increase in the number of cAB incorporated into the sequences. And finally, 
FRET experiments revealed that AB3 and AB4 duplexes gave the biggest difference in fluorescence 
quenching between duplexes with cis- and trans-cAB.  
 
 
 
 
 
 
 
 
Figure 3-18. Schematic representation of the photoregulation of DNA hybridization with cAB. 
cis-form 
trans-form 
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Taken together, these results do suggest that cyclic azobenzene could be used for 
spatiotemporal regulation of DNA functions such as transcription, in a turn-on fashion.  This can 
be achieved by tethering cAB units to specific positions on the T7 promoter, then the transcription 
by the T7-RNA polymerase can be reversibly photoregulated by cis-trans isomerization of cAB.  
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CHAPTER 4: Results and discussions  
(Site-specific labeling of DNA by IEDDA) 
 
4.1 Overview of the synthesis of trans-cyclooctene derivatives 
The main goal of this project is to synthesize trans-cyclooctene derivatives for introduction 
into DNA sequences, such as 125 and 126 (Scheme 4-1), using the phosphoramidite chemistry 
based solid phase synthesis, followed by Inverse Electron Demand Diels Alder reaction (IEDDA) 
with BODIPY-tetrazine 89, leading to the formation of fluorescently labeled DNA sequences 127 
and 128.  
Scheme 4-1. The general scheme for site-specific labeling of DNA using IEDDA between trans-
cyclooctene derivative and BODIPY-tetrazine adduct. 
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Commercially available 5-iododeoxyuridine 129 was first protected at 5’-OH with a DMTr 
group in order to increase its solubility. The protected compound 130 was obtained in 80% yield 
(Scheme 4-2).  
 
Scheme 4-2. Reagents and conditions: DMTr-Cl, pyridine, 80%. 
In order to synthesize the first trans-cyclooctene derivative 134, 1,5-cyclooctadiene 131 was 
treated with meta-chloroperbenzoic acid (m-CPBA) to give the corresponding epoxide 132 in a 
moderate 69% yield (Scheme 4-3). Nucleophilic substitution using lithium aluminum hydride 
LiAlH4 was then performed to open the epoxide ring and gave (Z)-cyclooct-4-enol 133 in 52% 
yield.117 Isomerization of 133 in a UVP-CL-500-ultraviolet crosslinker reactor at 254 nm in the 
presence of methyl benzoate as a sensitizer gave two isomers, (E)-cyclooct-4-enol 134-a as a major 
product in 32% and (E)-cyclooct-4-enol 134-b as a minor in 13% yield (Scheme 4-3). Separation 
of these two trans-isomers from the cis-cyclooctene 133 was performed by passing the reaction 
mixture through a column packed with AgNO3-impregnated silica gel. Trans-Cyclooctenes form 
water-soluble complexes with AgNO3, whereas cis-cyclooctene binds only weakly to AgNO3, so 
it can be eluted by a mixture of hexane-diethylether (1:9, v/v), while trans-cyclooctene is retained 
by the AgNO3-impregnated silica gel. Subsequent elution of the silica gel with aqueous ammonium 
hydroxide releases trans-cyclooctene from the silica gel. 
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Scheme 4-3. Reagents and conditions: a) m-CPBA, DCM, 69%; b) LiAlH4, THF, 52%; c) C6H5COOCH3, 
ether-hexane (9:1), 45%. 
The two trans-cyclooctenes 134-a and 134-b can be distinguished by NMR spectroscopy. 
Examination of the crown conformation structure of both isomers (Figure 4-1)118 clearly reveals 
that the hydrogen labeled as Ha is axially substituted and positioned close to the transannular 
alkene of the major isomer 134-a. This explains the relatively upfield chemical shift for Ha (3.36-
3.40 ppm) due to shielding by the alkene (Figure 4-2a).  While for the minor isomer 134-b, Ha is 
equatorial and therefore distant from the alkene. As a result, NMR signal is more down field (3.98-
4.03 ppm) (Figure 4-3a). 
 
 
Figure 4-1. The crown conformation structure of major 134-a and minor 134-b isomers. 
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 The stereochemistry of the two isomers was further confirmed by NOE experiments. When 
Ha is irradiated, a corresponding NOE signal was seen in the alkenic region of the major isomer 
130-a, indicating the close proximity of those two protons (Figure 4-2b).  However, NOE was not 
observed for the minor isomer 130-b (Figure 4-3b).   
a)  
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
Figure 4-2. a) 1H NMR spectrum of major 134-a, b) NOE spectrum of the same compound in acetone-d6. 
Ha 
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a) 
b) 
Figure 4-3. a) 1H NMR spectrum of minor 134-b, b) NOE spectrum of the same compound in acetone-d6. 
The major isomer 134-a was further treated with propargyl bromide to afford the 
propargylated compound 135 in a moderate yield 61%. NOE experiments was performed for the 
propargylated compound 135. When Ha is irradiated, a corresponding NOE signal was seen in the 
Ha 
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alkenic region, indicating the close proximity of those two protons (Figure 4-4a and b). This 
observation also indicates that the propargylation reaction did not affect the stereochemistry of the 
compound.  
a)  
 
 
 
 
 
 
 
 
b)    
 
 
 
 
 
 
 
 
 
 
Figure 4-4. a) 1H NMR spectrum of 135, b) NOE spectrum in acetone-d6. 
Ha 
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Reaction of 135 with the previously prepared 5’-O-DMTr-protected 5-iododeoxyuridine 130 
in the presence of copper (I) iodide, tetrakis(triphenylphosphine)palladium and DIPEA was 
expected to give Sonogashira coupling product 136, however, at this writing, this reaction has 
failed to give the desired product under various condition. Future work will further investigate this 
reaction. Once the desired product 136 is obtained, it will be transformed into the corresponding 
phosphoramidite for incorporation into DNA sequences 125 by solid phase synthesis (Scheme 4-
4).     
 
 
Scheme 4-4. Reagents and conditions: a) propargyl bromide, NaH, THF, 61%; b) CuI, [Pd(PPh)3]4, DIPEA; 
c) (2-cyanoethyl) -N,N-diisopropylphosphochloridite, DIPEA, THF; (d) Solid phase DNA synthesis. 
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The other trans-cyclooctene derivatives 139 and 141 were synthesized from the same starting 
material 1,5-cyclooctadiene 131. First, treatment of 131 with ethyl diazoacetate in the presence of 
catalytic amount of rhodium acetate Rh2(OAc)4 gave two isomers, exo-isomer 137-a and endo-
isomer 137-b in 58 and 41% yields, respectively. Reduction of both isomers in separate reactions 
using diisobutylaluminium hydride (DIBAL) at -78°C gave the corresponding reduced 
compounds, 138 in 93% yield and 140 in 81%, respectively. Photoisomerization of 138 and 140 
using the procedure previously described in this section gave the corresponding trans-isomers 139 
(39% yield) and 141 (40% yield) (Scheme 4-5). 
 
Scheme 4-5. Reagents and conditions: a) Rh2(OAc)4, ethyl diazoacetate, 58% exo, 41% endo; b) DIBAL, 
THF, 93%; c) C6H5COOCH3, ether-hexane (9:1), 39%  d) DIBAL, THF, 81%; e) C6H5COOCH3, ether-
hexane (9:1), 40%. 
Propargylation reaction of 141 using propargyl bromide in the presence of sodium hydride 
gave the corresponding product 142 in 64% yield. In future work, the latter compound 142 will be 
treated with 5’-O-DMTr-5-iododeoxyuridine 130 under the Sonogashira coupling conditions to 
furnish the compound 143 which will then be transformed into the corresponding phosphoramidite 
for incorporation into DNA sequences 126 using solid phase synthesis (Scheme 4-6).  
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Scheme 4-6. Reagents and conditions: a) propargyl bromide, NaH, THF, 64%; b) CuI, [Pd(PPh)3]4, DIPEA; 
c) (2-cyanoethyl) -N,N-diisopropylphosphochloridite, DIPEA, THF; (d) Solid phase DNA synthesis. 
4.2 BODIPY-tetrazine synthesis 
The first attempt to synthesize BODIPY-tetrazine 89 followed a previously reported 
procedure (Scheme 4-7).104 
 
Scheme 4-7. Reagents and conditions: a) i. TFA, DCM, ii. DDQ, iii. DIPEA, iv. BF3OEt2, 35%; b) 
Zn(OTf)2, NH2NH2 hydrate, CH3CN, DMF.   
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Thus BODIPY 146 was prepared in 35% yield by first reacting 3-formyl benzonitrile 144 with 
2,4-dimethylpyrrole 145 in the presence of trifluoroacetic acid TFA, followed by oxidation with 
2,3-dichloro-5,6-dicyanobenzoquinone DDQ, and then complexation with BF3.OEt2 in the 
presence of DIPEA, However, the following transformation to introduce the tetrazine ring as in 89 
failed under various conditions (Table 4-1). 
Table 4-1. The various conditions used for Bodipy-tetrazine synthesis.   
Reagent Conditions Results 
Zn(OTf)2 60°C, microwave, 18 h No desired product 
Zn(OTf)2 60°C, 24 h No desired product 
Zn(OTf)2 100°C, 18 h No desired product 
Ni(OTf)2 60°C, 24 h No desired product 
Sulfur 78°C (reflux), overnight No desired product 
 
Consequently, another synthetic approach was used (Scheme 4-8). Thus, the aldehyde group 
of 3-formyl benzonitrile 144 was first protected as acetal by the treatment with ethylene glycol in 
the presence of (±)-camphor-10-sulfonic acid (CSA) to give 148 in 95% yield. The corresponding 
tetrazine compound 149 was obtained in 41% yield by the reaction of 148 with acetonitrile in the 
presence of Ni(OTf)2 and hydrazine hydrate. Aqueous toluene sulfonic acid was subseqently used 
to deprotect the acetal protecting group to give tetrazine benzaldehyde 150 in 98% yield. Finally, 
following the same reaction sequence that was used for synthesizing 146, a product was isolated 
in 33% yield as a single spot on the TLC. Although this non-fluorescent compound has the 
characteristic color of tetrazines and 11B NMR and 19F NMR signals that correspond to BODIPY 
compounds, the identity of this compound could not be confirmed at this writing. 
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Scheme 4-8. Reagents and conditions: a) HOC2H4OH, CSA, benzene, 95%; b) Ni(OTf)2, NH2NH2 hydrate, 
CH3CN, DMF, 41%; c) TsOH, H2O, MeOH, 98%; d) i. TFA, DCM, ii. DDQ, iii. DIPEA, iv. BF3OEt2, 
33%. 
4.3 Conclusions and future work 
Two different trans-cyclooctene derivatives 135 and 142 were synthesized in moderate yields 
from the same starting material 1,5-cyclooctadiene 131. In addition, an alternative synthesis 
approach was pursued for the preparation of BODIPY-tetrazine compound.   
Future work of this project will explore conditions for the Sonogashira coupling reactions 
towards the synthesis of 2’-deoxyuridine derivatives 136 and 143 containing trans-cyclooctene 
derivatives. The latters will be transformed into corresponding phosphoramidite for incorporation 
into oligonucleotides to study the IEDAA reaction for labeling purposes. Future work will also 
aim to confirm the identity of the BODIPY-tetrazine product 89, and to develop this approach as 
a general method for synthesizing BODIPY-tetrazine conjugates. These conjguates will find 
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applications in labeling biomolecules through the IEDAA reactions, leading to fluorescent “turn 
on” with very low background noise. 
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CHAPTER 5: Experimental 
 
5.1 Instrumentation 
1H NMR spectra were measured at 300, 400 and 600 MHz with   Bruker Avance 300, 400 and 
600 Digital NMR spectrometers with 7.05, 9.4 and 14.1 Tesla Ultra shield magnets, respectively. 
Tetramethylsilane was used as an internal standard. 13C NMR spectra were measured at 75 MHz 
or 100 MHz, 31 P at 162 MHz, 11B at 128 MHz, and 19F at 376 MHz with the same instrument. 
Chemical shifts and coupling constants (J values) are given in ppm and Hz, respectively. The 
following deuterated solvents from C/D/N isotopes Inc. were used for preparation of NMR 
samples: dimethyl-d6 sulfoxide with 0.05% tetramethylsilane internal standard (99.9 atom % D), 
deuterated chloroform (99.9 atom % D), and deuterated oxide (99.9 atom % D). Low resolution 
mass spectra were obtained with a Bruker HCT Ultra LC/MS system with ESI interfaces, and the 
data were processed using Bruker Data Analysis software. UV/Vis spectra and melting 
temperature curves were recorded with Cary 4000 UV/Visible spectrophotometer. Fluorescence 
spectra were measured using QuantaMaster model QM-2001-4 cuvette-based L-format scanning 
spectrofluorometer from Photon Technology International (PTI) interfaced with FeliX32 software. 
Photoisomerization reactions were performed using Hoefer UVC 500 Ultraviolet Crosslinker. 
Circular Dichroism (CD) spectra were recorded using Jasco J-600 Circular Dichroism 
Spectrometer.  
5.2 Chromatography 
Silica gel (EMD, >230 mesh) was used for flash chromatography. Silver nitrate-impregnated 
silica gel was prepared using the following procedure.118  
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Flash silica gel (90.00 g) was suspended in water (100 ml) in a 2 L round bottom flask. The 
flask was covered with aluminum foil and a solution of silver nitrate (10 g) in water (10 ml) was 
added. The resulting mixture was thoroughly mixed. Water was evaporated under reduced pressure 
on a rotary evaporator (bath temperature ~ 65 °C) using a bump trap equipped with a coarse fritted 
disk. After the bulk water was removed, the residue was co-evaporated with toluene (2×200 ml) 
to remove the remaining trace amount of water. The silver nitrate impregnated silica gel was 
furthere dried in vacuo overnight at room temperature. 
Thin layer chromatography was performed on Silicycle SilicaPlate F-254 TLC plates using 
the following solvent mixtures: 
System A: hexane-diethyl ether (90:10, v/v) 
System B: hexane-diethyl ether (50:50, v/v) 
System C: hexane-diethyl ether (30:70, v/v) 
System D: dichloromethane-methanol (95:5, v/v) 
5.3 Solvents and chemicals 
Benzene, toluene and tetrahydrofuran THF were dried by heating under reflux over sodium in 
the presence of benzophenone for 4 h and then distilled. N,N-Diisopropylethylamine, and pyridine 
were dried by heating under reflux over calcium hydride for 2 h and then distilled in an atmosphere 
of nitrogen. Dimethylformamide (DMF) was dried by heating at 60°C for 2 h in the presence of 
calcium hydride, followed by distillation under reduced pressure. Dichloromethane and 
chloroform were dried by heating under reflux over phosphorus pentoxide for 2 h and then distilled 
in an atmosphere of nitrogen. All the distilled solvents were stored over activated 4 Å molecular 
sieves. All other reagents were purchased from Sigma-Aldrich or VWR Canlab without further 
purification prior to use unless stated otherwise. 
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5.4 Preparation of compounds 
11, 12-Dihydrodibenzo[c, g] [1, 2] diazocine-5-oxide 110 
 
2,2’-Dinitrodibenzyl  109 (6.09 g, 22.38 mmol) was dissolved in methanol (250 ml) followed 
by addition of sodium carbonate (18.68 g, 176.2 mmol) and lead powder (18.26 g, 88.13 mmol, 
200 mesh). The reaction mixture was stirred vigorously under reflux for 24 h, then the products 
were filtered and washed with dichloromethane. The filtrate and washing were combined and 
concentrated under reduced pressure. The residue was re-dissolved in dichloromethane (100 ml) 
and washed with saturated sodium bicarbonate (3×50 ml). The organic layer was dried (MgSO4) 
and concentrated under reduced pressure. The residue was purified by column chromatography on 
silica gel. The appropriate fractions, which were eluted with dichloromethane-hexane (40:60 v/v), 
were pooled and concentrated under reduced pressure to give the title compound as a pale yellow 
solid (3.09 g, 62 %). 
δH(CDCl3): 2.88 (1 H, ddd, J = 5.9, 9.6 and 14.4), 2.98 (1 H, ddd, J = 5.2, 10.0, and 14.9), 3.22 
(1 H, ddd, J = 5.1, 10.1, 14.6), 3.37(1 H, ddd, J = 5.9, 10.1, 15.0), 6.94(1 H, d, J = 7.8), 7.02 (2 
H, d, J = 4.0), 7.04 (1 H, d, J =7.6), 7.10-7.20 (4 H, m). 
These values are in agreement with the previously reported data.55 
 
2-Bromo-11,12-dihydrodibenzo[c,g][1,2]diazocine-6-oxide 111 
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To a solution of 11,12-dihydrodibenzo[c,g][1,2]diazocine-5-oxide 110 (1.60 g, 7.14 mmol) in 
acetic acid (16.0 ml), bromine (1.60 ml, 31.04 mmol) was added drop-wise. After the reaction 
mixture was heated at 50°C in a sealed flask for 2 days, the reaction was quenched by a drop-wise 
addition of sodium thiosulfate solution (40%) until the color changed from brown to pale yellow. 
The mixture was then extracted with dichloromethane (3×50 ml). The organic layers were 
combined and washed with water (2×50 ml) and saturated aqueous sodium bicarbonate solution 
(2×50 ml). The organic layer was dried (MgSO4) and concentrated under reduced pressure. The 
residue was purified by column chromatography on silica gel. The desired product was obtained 
upon evaporation of appropriate fractions, which were eluted with dichloromethane-hexane (40:60 
v/v), as a light brown solid (1.48 g, 69%).  
δH(CDCl3): 2.84 (1 H, ddd, J = 5.9, 9.6, and 14.8), 2.98 (1 H, ddd, J = 5.1, 9.9 and 14.8), 3.21 (1 
H, ddd, J = 5.1, 10.1, and 14.8), 3.36 (1 H, ddd, J = 5.9, 9.9, and 15.0), 6.82 (1 H, d, J = 8.4), 7.07 
(1 H, d, J = 7.5), 7.16–7.22 (3 H, m), 7.24–7.26 (2 H, m). 
These values are in agreement with the previously reported data.55 
 
2-Bromo-11,12-dihydrodibenzo[c,g][1,2]diazocine 112  
 
Phosphorus trichloride (8.30 ml, 95.1 mmol) was added slowly to a solution of 2-bromo-
11,12-dihydrodibenzo[c,g][1,2]diazocine-6-oxide 111 (1.80 g, 5.96 mmol) in dry benzene (25 ml) 
and the reaction mixture was heated under reflux for 24 h. Upon cooling, the reaction mixture was 
evaporated under reduced pressure. To the dark residue, hydrochloric acid (0.1 M, 10 ml) was 
added, followed by extraction with diethyl ether (3×50 ml). The organic layers were combined and 
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washed with saturated aqueous sodium bicarbonate (2×50 ml) and the organic layers were dried 
(MgSO4) and evaporated to dryness under reduced pressure. The residue was purified by column 
chromatography on silica gel. The desired product was obtained upon evaporation of appropriate 
fractions, which were eluted with dichloromethane-hexane (30:70 v/v), as a pale yellow solid 
(0.850 g, 50%). 
δH(CDCl3): 2.76 (2 H, m), 2.99 (2 H, br, m), 6.73 (1 H, d, J = 8.4), 6.85 (1 H, d, J = 7.8), 7.02 (1 
H, d, J = 7.5), 7.07 (1 H, t, J = 7.4), 7.15 (1 H, d, J = 1.6), 7.18 (1 H, t, J = 7.5), 7.26 (1 H, dd, J 
= 1.7 and 8.4). 
These values are in agreement with the previously reported data.  
 
11,12-Dihydrodibenzo[c,g][1,2]diazocine-2-carbonitrile 113 
 
To a solution of 2-bromo-11,12-dihydrodibenzo[c,g][1,2]diazocine 112 (1.15 g, 4.02 mmol) 
in dry N,N-dimethyl formamide (10 ml), copper (I) cyanide (0.54 g, 6.03 mmol) was added. After 
the reaction mixture was heated under reflux overnight, the products were cooled to room 
temperature, followed by addition of ethylenediamine (10% aqueous solution, 50 ml). The mixture 
was extracted with dichloromethane (3×50 ml). The organic layer was separated and successively 
washed with saturated aqueous sodium bicarbonate solution (3×50 ml) and water (3×50 ml). The 
organic layer was dried (MgSO4) and concentrated under reduced pressure. The residue was 
purified by column chromatography on silica gel. The desired product was obtained upon 
evaporation of appropriate fractions, which were eluted with dichloromethane-hexane (60:40 v/v) 
as a pale yellow solid (0.57 g, 61%).  
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δH(CDCl3): 2.78–2.87 (2 H, m), 3.00–3.07 (2 H, m), 6.87 (1 H, d, J = 7.7), 6.92 (1 H, d, J = 8.1), 
7.01 (1 H, d, J = 7.5), 7.08 (1 H, dt, J = 1.2 and 7.5), 7.19 (1 H, t, J = 7.5), 7.32 (1 H, d, J = 1.2), 
7.44 (1 H, dd, J = 1.4 and 8.0). 
These values are in agreement with the previously reported data.112 
 
11,12-Dihydrodibenzo[c,g][1,2]diazocine-2-carboxylic acid 114 
 
The carbonitrile 113(200 mg, 0.80 mmol) was placed in a solution of potassium hydroxide 
(6.00 g) in ethanol (60 ml) and water (15 ml) and heated under reflux for 4 h. Ethanol was removed 
under reduced pressure and the residue was treated with aqueous hydrochloric acid (6 M) until the 
mixture turned acidic (pH 4). The mixture was extracted with ethyl acetate (3×50 ml). The 
combined organic layers were washed with brine (2×30 ml), dried (MgSO4), and concentrated 
under reduced pressure to give the crude carboxylic acid which was purified by column 
chromatography on silica gel. The appropriate fractions, which were eluted with dichloromethane-
methanol (95:5 v/v), were combined and concentrated under reduced pressure to give the title 
compound as a light yellow solid (196 mg, 96%). 
δH(CDCl3): 2.83 (1 H, m), 2.89 (1 H, m), 3.04 (2 H, m), 6.87 (1 H, d, J = 7.8), 6.92 (1 H, d, J = 
8.1), 7.00 (1 H, d, J = 7.6), 7.05 (1 H, t, J = 7.7), 7.17 (1 H, t, J = 7.5), 7.76 (1 H, d, J = 1.2), 7.87 
(1 H, dd, J = 1.3 and 8.1). 
These values are in agreement with the previously reported data.55 
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(Z)-N-((2S,3S)-1,3-Dihydroxybutan-2-yl)-11,12-dihydrodibenzo[c,g][1,2]diazocine-2-
carboxamide 116 
 
To a solution of 11,12-dihydrodibenzo[c,g][1,2]diazocine-2-carboxylic acid 114 (200 mg, 
0.79 mmol) in dry N,N-dimethyl formamide (4.0 ml), D-threoninol 115 (70 mg, 0.67 mmol), N,N-
dicyclohexylcarbodiimide (164 mg, 0.79 mmol) and N-hydroxysuccinamide (92 mg, 0.79 mmol) 
were added. After the reaction mixture was stirred for 5 h at room temperature under a nitrogen 
atmosphere, the precipitate was removed by filtration and the filtrate was evaporated under 
reduced pressure. The oily residue was purified by column chromatography on silica gel. 
Evaporation of appropriate fractions, which were eluted by dicholoromethane-methanol (95:5 v/v), 
gave the title compound as a pale yellow foam (240 mg, 90%). 
δH (DMSO-d6): 1.01 (3 H, t, J = 6.1), 2.83-2.86 (2 H, m), 2.88-2.91 (2 H, m), 3.40-3.45 (1 H, m), 
3.51-3.55 (1 H, m), 3.81-3.84 (1 H, m), 3.85-3.88 (1 H, m), 4.56-4.61 (2 H, m, br, OH, ex), 6.88 
(1 H, d, J = 7.8), 6.92 (1 H, d, J = 8.1), 7.07 (1 H, t, J = 7.3), 7.10 (1 H, d, J = 7.2), 7.19 (1 H, dt, 
J = 7.19) (1 H, t, J = 7.2), 7.60 (1 H, d, J = 2.9), 7.66 (1 H, d, J = 8.1), 7.71 (1 H, d, J = 8.3, NH, 
ex). 
These values are in agreement with the previously reported data.55 
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(Z)-N-((2R,3S)-1-(bis(4-methoxyphenyl)(phenyl)methoxy)-3-hydroxybutan-2-yl)-11,12- 
dihydrodibenzo[c,g][1,2]diazocine-2-carboxamide 117 
 
 
(Z)-N-((2S,3S)-1,3-Dihydroxybutan-2-yl)-11,12-dihydrodibenzo[c,g][1,2]diazocine-2-
carboxamide 116 (70 mg, 0.21 mmol) was azeotroped with dry toluene (5 ml) and then dry pyridine 
(2×5 ml). The residue was dissolved in dry pyridine (10 ml) and then azeotroped to a volume of 
approximately 5 ml, followed by addition of 4,4’-dimethoxytrityl chloride (84 mg, 0.25 mmol) 
under nitrogen. The reaction mixture was stirred at room temperature for 1 h and triethylamine (1 
ml) was added. The products were poured into saturated aqueous sodium bicarbonate (20 ml) and 
extracted with dichloromethane (3×20 ml). The organic layers were combined, dried (MgSO4) and 
evaporated to dryness to give an oily product. The oily residue was purified by column 
chromatography on silica gel. The desired product was obtained upon evaporation of appropriate 
fractions, which were eluted with methanol-dichloromethane (1:99 v/v), as a pale yellow foam 
(110 mg, 83 %). 
δH(DMSO-d6): 0.97 (3 H, d, J = 6.0), 2.85-2.93 (5 H, m), 3.14-3.19 (1 H, m), 3.72 (6 H, s), 3.97-
4.06 (2 H, m), 4.53 and 4.55 (both d, J = 6.0, together 1 H, OH), 6.80-6.84 (4 H, m), 6.88 (1 H, d, 
J = 7.8), 6.96 (1 H, d, J = 8.0), 7.05 (1 H, t, J = 7.3), 7.10 (1 H, t, J = 7.3),  7.16-7.23 (8 H, m), 
7.34-7.38 (2 H, m), 7.63 (1 H, d, J = 10.2), 7.70 (1 H, ddd, J = 1.4, 1.4 and 6.9), 8.00 and 8.03 
(both d, J = 8.5, together 1 H) 
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These values are in agreement with the previously reported data.112 
 
(2S,3R)-4-O-Dimethoxytrityl-3-((Z)-11,12-dihydrodibenzo[c,g][1,2]diazocine-2- 
carboxamido)butan-2-yl(2-cyanoethyl) diisopropylphosphoramidite 118 
 
(Z)-N-((2R,3S)-1-O-Dimethoxytrityl-3-hydroxybutan-2-yl)-11,12-dihydrodibenzo[c,g][1,2] 
diazocine-2-carboxamide 117 (200 mg, 0.31mmol) was azeotroped with dry toluene (2×5 ml) and 
dissolved in dry tetrahydrofuran (3 ml), followed by addition of dry N,N-diisopropyl ethylamine 
(Hünigs base, DIPEA, 0.16 ml, 0.94 mmol), and (2-cyanoethyl)-N,N-diisopropyl 
phosphochloridite (110 mg, 0.47 mmol). The reaction mixture was stirred at room temperature for 
30 min. Triethylamine (2 ml) were added and the products were evaporated under reduced 
pressure. The residue was purified by column chromatography on silica gel. The desired product 
was obtained upon evaporation of appropriate fractions, which were eluted with hexane-
dichloromethane-triethylamine (28:70:2 v/v), as a pale yellow color glass (197 mg, 72%). 
δH(CDCl3 containing trace amount of triethylamine) include the following signals: 0.98 (2 H, t, J 
= 5.9), 2.28–2.32 (1 H, m, br), 2.80–2.87 (2 H, m, br), 2.98–3.03 (2 H, m, br), 3.17–3.32 (2 H, m, 
br), 3.50 (3 H, br), 3.79 (6 H, s), 3.31–4.44 (1 H, m, br), 6.22, 6.26, 6.40, 6.45 (four sets of doublets 
that represent the NH proton, two diastereomers + rotamers, d, J = 8.8), 6.78–6.80 (4 H, br), 6.86 
93 
  
(d, J = 7.5) and 6.90 (d, J = 7.9) (these two sets of signals integrate together 2 H), 6.99 (t, J = 7.3) 
and 7.03 (t, J = 7.4) (these two sets of signals integrate together 2 H), 7.40 (2 H, t, J = 8.3). 
δp [CDCl3]: 147.84 and 148.38. 
These values are in agreement with the previously reported data.112  
 
5′-O-(4,4′-Dimethoxytrityl)-5-iodo-2′-deoxyuridine 130 
 
 
 
 
 
5-Iodo-2′-deoxyuridine 129(1.00 g, 2.82 mmol) was azeotroped with dry toluene (2×10 ml). 
The residue was dissolved in dry pyridine (20 ml) and azeotroped to a volume of approximately 
10 ml. To the solution, 4,4’-dimethoxytrityl chloride (1.15 g, 3.39 mmol) was added under 
nitrogen. After the reaction mixture was stirred for 1 h at room temperature, ice-cold water (25 ml) 
was added. The products were extracted with dichloromethane (3×30 ml). The organic layers were 
combined, dried over MgSO4, and evaporated to dryness to obtain an oily product. The oily residue 
was purified by column chromatography on silica gel. The desired product was obtained upon 
evaporation of appropriate fractions, which were eluted with methanol-dichloromethane (2:99 
v/v), as a while foam (1.48 g, 80 %). 
Rf (System D): 0.40 
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δH (CDCl3): 2.28-2.39 (1 H, m), 2.46-2.52 (1 H, m), 3.38-3.46 (2 H, m), 3.82 (6 H, s), 4.07 (1 H, 
m), 4.55-4.57 (1 H, m), 6.32 (1 H, dd, J = 7.6 and 6.0), 6.87 (4 H, d, J = 8.8), 7.25-7.36 (9 H, m), 
8.14 (1 H, s). 
δC (CDCl3): 41.4, 55.2, 63.5, 69.8, 72.2, 85.3, 86.2, 86.9, 113.3, 127.0, 128.0, 130.0, 130.1, 135.4, 
135.5, 143.8, 144.4, 151.6, 158.6, 162.2.  
 
 (Z)-9-Oxabicyclo[6.1.0]non-4-ene 132117 
 
1,5-Cyclooctadiene 131 (30.0 g, 0.277 mol) was dissolved in dry dichloromethane (350 ml), 
followed by drop-wise addition of a solution of meta-chloroperoxybenzoic acid (55.47 g, 0.2911 
mol) in dry dichloromethane (650 ml). After the addition was complete, the reaction mixture was 
stirred for 4 h at room temperature. The products were then filtered and the filtrate was washed 
successively with 5% aqueous sodium hydroxide solution (3×100 ml), sodium bicarbonate 
solution (3×100 ml) and water (3×100 ml). The organic phase was dried (MgSO4) and evaporated 
under reduced pressure to remove dichloromethane. Distillation of the crude mixture under 
reduced pressure (b.p 86–88°C/9 mmHg) gave the title compound as a colorless oil (23.76 g, 69%).   
Rf (System A): 0.45 
δH (CDCl3): 1.98-2.10 (4 H, m), 2.11-2.16 (2 H, m), 2.35-2.46 (2 H, m), 3.00-3.04 (2 H, m), 5.52-
5.60 (2 H, m).  
δC (CDCl3): 23.6, 28.1, 56.6, 128.8. 
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(Z)-Cyclooct-4-enol 133117 
   
(Z)-9-Oxabicyclo[6.1.0]non-4-ene 132 (23.40 g, 0.1884 mol) was added drop-wise to a 
suspension of lithium aluminium hydride (4.04 g, 0.106 mol) in  dry tetrahydrofuran (400 ml) at 
0°C. The reaction mixture was stirred under reflux overnight. After the reaction was cooled to 
room temperature, water (20 ml) and dry MgSO4 (2.00 g) were added and the mixture was stirred 
for 20 min. The mixture was then filtered and washed with diethyl ether. The filtrate and the 
washing were dried (MgSO4) and evaporated under reduced pressure to remove the solvent. 
Distillation of the crude mixture under reduced pressure (b.p 95–97°C/9 mmHg) gave the title 
compound as a colorless oil (12.28 g, 52%).    
Rf (System C): 0.56 
δH (CDCl3): 1.48-1.56 (1 H, m, OH), 1.58-1.73 (1 H, m), 1.79-1.95 (4 H, m), 2.05-2.16 (4 H, m), 
2.24-2.33 (1 H, m), 3.75-3.81 (1 H, m), 5.54-5.61 (1 H, m), 5.65-5.71 (1 H, m). 
δC (CDCl3): 22.7, 24.9, 25.6, 36.3, 37.6, 72.6, 129.5, 130.1. 
 
rel-(1R-4E-pR)-Cyclooct-4-enol (major) 134-a and rel-(1R-4E-pS)-cyclooct-4-enol (minor) 
134-b 
 
These compounds were synthesized from (Z)-cyclooct-4-enol by modification of a previously 
published procedure.86 
96 
  
(Z)-Cyclooct-4-enol 133 (1.00 g, 7.92 mmol) and methyl benzoate (1.10 g, 8.15 mmol)  were 
dissolved in hexane-diethyl ether (200 ml, 1:9, v/v) and transferred in equal volumes to 4 Petri 
dishes (9.0 cm diameter). The Petri dishes were placed in a UVP-CL-500-ultraviolet crosslinker 
reactor and irradiated at 20×100 µJ/cm2. At intervals of 25–30 min, the reaction mixture was 
passed through a column packed with 25 g of silica gel impregnated with 10% silver nitrate. The 
column was equilibrated with ether prior sample loading. The mixture passing through the column 
was placed back into the UV crosslinker for further irradiation. After total 7 h irradiation, the silica 
gel was transferred to a flask and stirred in an ammonium hydroxide solution (150 ml, 28%) for 5 
min. Dichloromethane (150 ml) was added and stirring was continued for 5 min. The mixture was 
filtered and the aqueous layer was extracted with dichloromethane (3×50 ml). The combined 
organic phases were washed with water (3×50 ml) and dried (MgSO4). After evaporation of the 
solvents, the two diastereomers of the product were isolated by column chromatography on silica 
gel (hexane-diethyl ether, 90:10 v/v) as colorless oils (major: 318 mg, 32%; minor: 126 mg, 13%). 
Major 134-a 
Rf (System C): 0.55 
δH (CDCl3): 1.55-1.72 (3 H, m), 1.93-1.99 (4 H, m), 2.24-2.37 (3 H, m), 3.44-3.48 (1 H, m), 5.35-
5.43 (1 H, m), 5.50-5.62 (1 H, m).  
δC (CDCl3): 31.2, 32.6, 34.3, 41.0, 44.5, 77.7, 132.7, 135.0. 
Minor 134-b 
Rf (System C): 0.73 
δH (CDCl3): 1.22-1.32 (1 H, m), 1.63-1.71 (1 H, m), 1.77-1.91 (4 H, m), 2.08-2.19 (2 H, m), 2.21-
2.29 (2 H, m), 2.34-2.44 (1 H, m), 4.04-4.07 (1 H, m), 5.53-5.64 (2 H, m).  
δC (CDCl3): 27.6, 29.3, 34.0, 34.1, 42.9, 67.4, 133.0, 134.2. 
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rel-(1R-4E-pR)-5-(Prop-2-yn-1-yloxy)cyclooct-1-ene 135 
 
A solution of rel-(1R-4E-pR)-cyclooct-4-enol 134-a (275 mg, 2.18 mmol) in dry 
tetrahydrofuran (3 ml) was added dropwise to a suspension of sodium hydride (60% in mineral 
oil, 260 mg, 6.54 mmol) in dry tetrahydrofuran (5 ml) at 0°C (ice-water bath). The mixture was 
stirred at room temperature for 30 min. Subsequently, propargyl bromide (519 mg, 4.36 mmol) 
was added dropwise at 0°C. After the mixture was stirred at room temperature overnight, the 
reaction was quenched by careful addition of brine (15 ml). The aqueous phase was extracted with 
diethyl ether (2×20 ml), and the organic extracts were dried with MgSO4 and concentrated under 
reduced pressure. The residue was purified by column chromatography, eluting with hexane-
diethyl ether (90:10 v/v) to afford the title compound (218 mg, 61%) as a pale yellow oil. 
Rf (System A): 0.56 
δH (CDCl3): 1.46-1.59 (2 H, m), 1.78-1.88 (2 H, m), 1.89-2.02 (2 H, m), 2.09 (1 H, dd, J = 5.0 and 
13.0), 2.22-2.32 (1 H, m), 2.35-2.41 (3 H, m), 3.21-3.25 (1 H, m), 4.06 (2 H, ddd, J = 4, 16 and 20 
), 5.37-5.45 (1 H, m), 5.55-5.63 (1 H, m).  
δC (CDCl3): 31.4, 32.8, 34.4, 37.5, 40.4, 55.2, 73.5, 80.4, 84.5, 132.3, 135.3.  
 
Ethyl (1R,8S,9R,4Z)-bicyclo [6.1.0]non-4-ene-9-yl-10-ate (exo) 137-a and ethyl (1R,8S,9S,4Z)-
bicyclo [6.1.0]non-4-ene-9-yl-10-ate (endo) 137-b100 
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1,5-Cyclooctadiene 131 (10 ml, 81.5 mmol) was added under nitrogen to a dry round-bottom 
flask containing  rhodium(II) acetate (23.5 mg, 0.053 mmol) and the solution was stirred 
vigorously. Ethyl diazoacetate (8 ml, 1.00 mmol, 15% in toluene) was added to the solution via a 
syringe pump over 12 h. After the addition was complete, the reaction was stirred overnight and 
then transferred directly to a silica gel column and purified (0 to 1% diethyl ether/hexane), yielding 
0.861 g (42%) of endo-ester and 1.182 g (58%) of exo-ester. 
exo-ester 137-a 
Rf (System A): 0.55 
δH (CDCl3): 1.20 (1 H, t, J = 4.6), 1.27 (3 H, t, J = 7.2), 1.45-1.54 (2 H, m), 1.56-1.61 (2 H, m), 
2.06-2.14 (2 H, m), 2.17-2.25 (2 H, m), 2.29-2.35 (2 H, m), 4.12 (2 H, q, J = 7.2), 5.61-5.69 (2 H, 
m).  
δC (CDCl3): 14.3, 26.6, 27.7, 27.8, 28.2, 60.2, 129.9, 174.4.  
endo-ester 137-b 
Rf (System A): 0.69 
δH (CDCl3): 1.28 (3 H, t, J = 7.2), 1.38-1.44 (2 H, m), 1.72 (1 H, t, J = 8.8), 1.80-1.89 (2 H, m), 
2.03-2.12 (2 H, m), 2.17-2.27 (2 H, m), 2.48-2.56 (2 H, m), 4.13 (2 H, q, J = 7.2), 5.59-5.66 (2 H, 
m).  
δC (CDCl3): 14.4, 21.2, 22.6, 24.1, 27.0, 59.7, 129.4, 172.3.  
 
(1R,8S,9R,4Z)-Bicyclo [6.1.0]non-4-ene-9-ylmethanol 138100 
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To a solution of ethyl (1R,8S,9R,4Z)-bicyclo [6.1.0]non-4-ene-9-yl-10-ate (exo) 137-a (1.92 
g, 9.84 mmol) in dry tetrahydrofuran (40 ml) in a round bottom flask cooled at -78°C (dry ice – 
acetone bath) was added a solution of diisobutylaluminium hydride (25 ml, 24.79 mmol, 80% in 
THF) dropwise via a syringe. After the reaction was stirred at -78°C for 30 min, the reaction was 
quenched by addition of a generous excess of brine solution (20 ml) and then warmed to room 
temperature. The resulting heterogeneous mixture was filtered, and the filter cake was washed with 
diethyl ether (15 ml). The filtrate and washing were combined and extracted with diethyl ether 
(3×20 ml). The organic layers were combined and concentrated under reduced pressure. The 
residue was purified through a short silica gel column eluting with hexane-diethyl ether (80:20 
v/v) to yield the title compound as a colorless oil (1.397 g, 93%). 
Rf (System C): 0.55  
δH (CDCl3): 0.64-0.70 (1 H, m), 0.75-0.83 (2 H, m), 1.38-1.47 (2 H, m), 2.04-2.22 (4 H, m), 2.27-
2.34 (2 H, m), 3.49 (2 H, d, J = 7.2), 5.61-5.69 (2 H, m). 
δC (CDCl3): 22.1, 27.1, 28.9, 29.0, 67.3, 130.1. 
 
(1R,8S,9S,4Z)-Bicyclo [6.1.0]non-4-ene-9-ylmethanol 140 
 
To a solution of ethyl (1R,8S,9S,4Z)-bicyclo[6.1.0]non-4-ene-9-yl-10-ate (endo) 137-b (1.43 
g, 7.32 mmol) in dry tetrahydrofuran (40 ml) in a round bottom flask at -78°C (dry ice–acetone) 
was added dropwise a solution of diisobutylaluminium hydride (18 ml, 18.31 mmol, 80% in THF). 
After the reaction mixture was stirred at -78°C for 30 min, the reaction was quenched by addition 
of a generous excess of brine solution (20 ml) and then warmed to room temperature. The resulting 
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heterogeneous mixture was filtered, and the filter cake was washed with ether (15 ml). The filtrate 
and washing were combined and extracted with diethyl ether (3×20 ml). The organic layers were 
combined and concentrated under reduced pressure. The residue was purified through a short silica 
gel column eluting with hexane-diethyl ether (85:15 v/v) to yield the title compound as a colorless 
oil (0.901 g, 81%). 
Rf (System C): 0.60 
MS-ESI+ found 153.1 for [M+H]+, C10H17O
+ required 153.2. 
δH (CDCl3): 0.99-1.06 (1 H, m), 1.10-1.19 (1 H, m), 1.35 (1 H, s), 1.54-1.64 (2 H, m), 1.96-2.16 
(4 H, m), 2.27-2.34 (2 H, m), 3.49 (2 H, d, J = 7.2), 5.61-5.69 (2 H, m). 
δC (CDCl3): 19.0, 20.7, 23.8, 27.6, 60.3, 129.7. 
 
rel-(1R,8S,9R,4E)-Bicyclo[6.1.0]non-4-ene-9-ylmethanol 139 
   
This compound was synthesized using a modified literature procedure.86 A solution of 
(1R,8S,9R,4Z)-bicyclo [6.1.0]non-4-ene-9-ylmethanol 138 (0.690 g, 4.63 mmol) and methyl 
benzoate (1.23 g, 9.06 mmol) in hexane-diethyl ether (150 ml, 1:9 v/v) was transferred in equal 
volumes to 3 Petri dishes (9.0 cm diameter). The Petri dishes were placed in a UVP-CL-500-
ultraviolet crosslinker reactor and irradiated at 20×100 µJ/cm2. At intervals of 25-30 min, the 
reaction mixture was passed through a column packed with 25 g of silica gel impregnated with 
10% silver nitrate. The column was equilibrated with ether prior to loading. The mixture passing 
through the column was placed back into the UV crosslinker for further irradiation. After total 7 h 
irradiation the silica gel was transferred to a flask and stirred in an ammonium hydroxide solution 
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(100 ml, 28%) for 5 min. Dichloromethane (100 ml) was added and stirring was continued for 5 
min. The mixture was filtered and the aqueous layer was extracted with dichloromethane (3×30 
ml). The combined organic phases were washed with water (3×30 ml) and dried (MgSO4). After 
evaporation of the solvents, the product was isolated by flash chromatography on silica gel 
(hexane-diethyl ether 80:20 v/v) as colorless oil (270 mg, 39%). 
Rf (System C): 0.53 
δH (CDCl3): 0.35-0.46 (2 H, m), 0.47-0.55 (1 H, m), 0.56-0.66 (1 H, m), 0.83-0.94 (1 H, m), 1.89-
1.99 (2 H, m), 2.20-2.34 (3 H, m), 2.38-2.42 (1 H, m), 3.49-3.57 (2 H, m), 5.11-5.19 (1 H, m), 
5.86-5.94 (1 H, m).  
δC (CDCl3): 20.6, 21.6, 27.7, 28.3, 32.7, 33.8, 38.4, 67.5, 131.2, 138.3. 
 
rel-(1R,8S,9S,4E)-Bicyclo[6.1.0]non-4-ene-9-ylmethanol 141 
 
 
 (1R,8S,9S,4Z)-Bicyclo [6.1.0]non-4-ene-9-ylmethanol  140 (0.704 g, 4.63 mmol)  and (1.27 
g, 9.34 mmol) methyl benzoate were dissolved in hexane-diethyl ether (150 ml, 1:9 v/v) and 
transferred in equal volumes to 3 Petri dishes (9.0 cm diameter). The Petri dishes were placed in 
an UVP-CL-500-ultraviolet crosslinker reactor and irradiated at 20×100 µJ/cm2. At intervals of 
25-30 min, the reaction mixture was passed through a column packed with 25 g of silica gel 
impregnated with 10% silver nitrate. The column was equilibrated with ether prior to loading. The 
mixture passing through the column was placed back into the UV crosslinker for further 
irradiation. After total 7 h irradiation the silica gel was transferred to a flask and stirred in an 
ammonium hydroxide solution (100 ml, 28%) for 5 min. Dichloromethane (100 ml) was added 
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and stirring was continued for 5 min. The mixture was filtered and the aqueous layer was extracted 
with dichloromethane (3×30 ml). The combined organic phases were washed with water (3×30 
ml) and dried (MgSO4). After evaporation of the solvents, the product was isolated by flash 
chromatography on silica gel (hexane-diethyl ether 80:20 v/v) as colorless oil (284 mg, 40%). 
Rf (System C): 0.58 
MS-ESI+ found 153.1 for [M+H]+, C10H17O
+ required 153.2. 
δH (CDCl3): 0.54-0.62 (1 H, m), 0.68-0.81 (2 H, m), 0.97-1.08 (1 H, m), 1.19-1.27 (1 H, m), 1.85-
1.94 (2 H, m), 2.08-2.13 (1 H, m), 2.15-2.26 (2 H, m), 2.28-2.35 (1 H, m), 3.49-3.57 (2 H, m), 
5.10-5.18 (1 H, m), 5.82-5.90 (1 H, m).  
δC (CDCl3): 18.0, 19.1, 20.9, 27.3, 27.5, 33.8, 34.3, 59.5, 131.2, 138.4. 
 
rel-(1R,8S,9S,4E)-9-((Prop-2-yn-1-yloxy)methyl)bicyclo[6.1.0]non-4-ene 142 
 
A solution of rel-(1R,8S,9S,4E)-bicyclo[6.1.0]non-4-ene-9-ylmethanol 141 (320 mg, 2.10 
mmol) in dry tetrahydrofuran (3 ml) was added dropwise to a suspension of sodium hydride (60% 
in mineral oil, 252 mg, 6.31 mmol) in dry tetrahydrofuran (5 ml) at 0°C. The mixture was stirred 
at room temperature for 30 min. Subsequently, propargyl bromide (500 mg, 4.21 mmol) was added 
dropwise at 0°C. The mixture was stirred at room temperature overnight. The reaction was 
quenched by careful addition of brine (15 ml). The aqueous phase was extracted with diethyl ether 
(2×20 mL), the organic extracts were dried with MgSO4 and concentrated under reduced pressure. 
The residue was purified by column chromatography, eluting with hexane-diethyl ether (90:10 
v/v) to afford the title compound (255 mg, 64%) as a pale yellow oil. 
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Rf (System C): 0.58  
δH (CDCl3): 0.59-0.67 (1 H, m), 0.73-0.85 (2 H, m), 0.97-1.08 (1 H, m), 1.23-1.31 (1 H, m), 1.88-
1.97 (2 H, m), 2.11-2.16 (1 H, m), 2.19-2.30 (2 H, m), 2.32-2.38 (1 H, m), 2.41 (1 H, t, J = 2.4), 
3.46 (2 H, d, J = 7.6), 4.12 (2 H, d, J = 2.4), 5.13-5.21 (1 H, m), 5.85-5.93 (1 H, m).  
δC (CDCl3): 17.9, 19.0, 22.7, 27.4, 27.7, 33.8, 34.5, 57.7, 66.8, 74.1, 80.0, 131.3, 138.5.  
 
10-(3-Cyanophenyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-
f][1,3,2]diazaborinin-4-ium-5-uide 146104 
 
To a solution of 3-formylbenzonitrile 144 (1.00 g, 7.63 mmol) and 2,4-dimethylpyrrole 145 
(1.70 ml, 16.5 mmol) in dry dichloromethane (50 ml) under a nitrogen atmosphere was added 
trifluoroacetic acid (20 µl, 0.261 mmol) and the reaction mixture was stirred at room temperature. 
After 30 min, TLC (solvent system: B) showed disappearance of 3-formylbenzonitrile. A solution 
of 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ, 1.73 g, 7.60 mmol) in dry dichloromethane (50 
ml) was added drop-wise followed by N,N-diisopropylethylamine (15.5 ml, 88.90 mmol) and BF3 
• OEt2 (15.5 ml, 125.6 mmol,  ~45% BF3 content). The reaction was allowed to stir overnight after 
which water (25 ml) was added and the aqueous phase was extracted with dichloromethane (3×25 
ml). The combined organic extracts were dried with MgSO4 and concentrated under reduced 
pressure. The crude mixture was purified using column chromatography (dichloromethane-hexane 
40:60 v/v) to give the title compound (913 mg, 35%) as a red solid. 
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Rf (System B): 0.53 
δH (DMSO-d6): 1.33 (6 H, s), 2.46 (6 H, s), 6.22 (2 H, s), 7.76-7.79 (2 H, m), 8.02 (1 H, m), 8.04-
8.07 (1 H, m). 
δC (DMSO-d6): 14.7 (4 C), 112.9, 118.6, 122.2, 130.9, 131.1, 132.3, 133.6, 133.7, 135.6, 139.5, 
143.0, 156.0.  
δB (DMSO-d6): 0.57 (t, J = 33.3). 
δF(DMSO-d6): -143.57 (m).  
 
3-(1,3-Dioxolan-2-yl)benzonitrile 148 
 
To a solution of 3-formylbenzonitrile 144 (1.00 g, 7.63 mmol) and (±)-camphor-10-sulfonic 
acid (0.354 g, 1.53 mmol) in dry benzene (50 ml) under a nitrogen atmosphere was added  freshly 
distilled ethylene glycol 147 (1.42 g, 22.9 mmol). The reaction mixture was heated under reflux 
for 3 h. Upon cooling, a saturated aqueous sodium bicarbonate solution (50 ml) was added and the 
aqueous phase was back-extracted with dichloromethane (3×25 ml). The combined organic 
extracts were dried with MgSO4 and concentrated under reduced pressure. Flash column 
chromatography eluting hexane-diethyl ether (50:50 v/v) gave the desired product as a colorless 
oil (1.27 g, 95%).  
Rf (System B): 0.38 
MS-ESI+ found 176.0 for [M+H]+, C10H10NO2
+ required 176.2. 
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δH (CDCl3): 4.04-4.08 (2 H, m), 4.09-4.14 (2 H, m), 5.83 (1 H, s), 7.49 (1 H, t, J = 7.6), 7.65 (1 H, 
d, J = 7.6), 7.71 (1 H, d, J = 7.6), 7.79 (1 H, s). 
δC (CDCl3): 65.4 (2 C), 102.2, 112.5, 118.5, 129.2, 130.2, 130.9, 132.6, 139.7. 
 
3-(3-(1,3-Dioxolan-2-yl)phenyl)-6-methyl-1,2,4,5-tetrazine 149 
 
3-(1,3-Dioxolan-2-yl)benzonitrile 148 (106 mg, 0.61 mmol), acetonitrile (320 μl, 6.05 mmol), 
hydrazine hydrate (1.18 ml, 37.51 mmol) and nickel trifluoromethanesulfonate (112 mg, 0.31 
mmol) were combined and sealed in a screw cap vial and stirred at 60°C for 24 h. Upon cooling 
to room temperature, a solution of sodium nitrite (835 mg, 12.1 mmol) in H2O (5 mL) was added. 
The solution was acidified by dropwise addition of 1 M hydrochloric acid to pH 3. The magenta 
colored mixture was extracted with diethyl ether (3×20 ml), the organic phase was dried over 
MgSO4 and evaporated under reduced pressure. Purification of the residue by flash column 
chromatography eluting with hexane-diethyl ether (80:20 v/v) afforded the desired product (60 
mg, 41%) as a magenta crystalline solid. 
Rf (System B): 0.38 
MS-ESI+ found 245.0 for [M+H]+, C12H13N4O2
+ required 245.2. 
δH (CDCl3): 3.12 (3 H, s), 4.08-4.15 (2 H, m), 4.16-4.22 (2 H, m), 5.95 (1 H, s), 7.63 (1 H, dd, J = 
7.7, 7,8), 7.75 (1 H, d, J = 7.6), 8.61(1 H, d, J = 7.6), 8.75 (1 H, s). 
δC (CDCl3): 21.2, 65.5 (2 C), 103.3, 126.2, 128.7, 129.4, 130.7, 131.9, 139.4, 163.9, 167.4. 
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3-(6-Methyl-1,2,4,5-tetrazin-3-yl)benzaldehyde 150 
 
3-(3-(1,3-Dioxolan-2-yl)phenyl)-6-methyl-1,2,4,5-tetrazine 149 (25 mg, 0.102 mmol) and 
para-toluenesulfonic acid monohydrate (20 mg, 0.102 mmol) were mixed and stirred in a mixture 
of methanol (5 ml) and water (1 ml) overnight. The reaction was quenched by the addition of 
saturated aqueous sodium bicarbonate solution (10 ml) and the aqueous phase was extracted with 
dichloromethane (3×15 ml). The combined organic extracts were dried with MgSO4 and 
concentrated under reduced pressure. The residue was purified by flash column chromatography 
on silica gel. Evaporation of the appropriate fractions, which were eluted with hexane-diethyl ether 
(70:30 v/v), gave the desired product as a magenta crystalline solid (20 mg, 98%).  
Rf (System B): 0.53 
δH (CDCl3): 3.16 (3 H, s), 7.81 (1 H, t, J = 7.7), 8.18 (1 H, d, J = 7.6), 8.89 (1 H, d, J = 7.6), 9.13 
(1 H, s). 
δC (CDCl3): 22.7, 125.5, 129.8, 130.1, 132.5, 133.3, 137.3, 163.3, 167.9, 191.4. 
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5,5-Difluoro-1,3,7,9-tetramethyl-10-(3-(6-methyl-1,2,4,5-tetrazin-3-yl)phenyl)-5H-
dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide 89 
 
To a solution of 3-(6-methyl-1,2,4,5-tetrazin-3-yl)benzaldehyde 150 (20 mg, 0.099 mmol) and 
2,4-dimethylpyrrole 145 (22 µl, 0.22 mmol) in dry dichloromethane (3 ml) under a nitrogen 
atmosphere was added trifluoroacetic acid (5 µl, 0.065 mmol). After the reaction mixture was 
stirred at room temperature for 30 min, a solution of 2,3-dichloro-5,6-dicyanobenzoquinone 
(DDQ, 23 mg, 0.099 mmol) in dry dichloromethane (3 ml), followed by N,N-
diisopropylethylamine (203 µl, 1.17 mmol) and BF3•OEt2 (179 µl, 1.94 mmol,  ~45% BF3 content) 
were added. The reaction mixture was stirred overnight after which water (5 ml) was added and 
the aqueous phase was extracted with dichloromethane (3×15 ml). The combined organic extracts 
were dried with MgSO4 and concentrated under reduced pressure. The crude mixture was purified 
using column chromatography (hexane-diethyl ether 70:30 v/v) to give the title compound (14 mg, 
33%) as a red solid. 
Rf (System A): 0.58 
No clear 1H NMR and 13C NMR spectra were obtained for this compound 
δB (DMSO-d6): 0.39 (t, J = 33.3). 
δF(DMSO-d6): -146.09 (q, J = 33.0). 
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DNA synthesis 
AB0 and 5’-FAM were synthesized by Alpha DNA’s lab using standard ABI 1.0 µmol cycle. 
The rest of the sequences AB1, AB1-1, AB1-2, AB2, AB2-1, AB2-2, AB3 and AB4 were synthesized 
by Dr. Richard Pon’s DNA lab using standard ABI 0.2 µmol cycle with the following 
modifications: 
- 10 min coupling at cAB position. 
- 5 min coupling at the base immediately after cAB. 
After solid phase synthesis was complete, the products were cleaved from solid support and 
deprotected by incubation with an equal volume of ammonium hydroxide/methylamine (AMA) at 
65°C for 5 min. After lyophilization, the products were purified by polyacrylamide gel 
electrophoresis. 
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